1800+ experts will join the Global Bioeconomy Summit – European Biotechnology News

More than 1,800 attendees already registered for the Global Bioeconomy Summit 2020. The conference takes place virtually from November 16 to 20.

First editions of the summit took place in Berlin in 2015 and 2018, this year it will be delivery fully virtually. The digital conference event with more than 1,800 participants is financed by the Federal Ministry of Education and Research (BMBF). The programme is brought together by the International Advisory Council on Global Bioeconomy (IAC), a body that was formed as part of the first GBS in 2015 and has been organizing the summits ever since.

5 plenary sessions, 12 interactive workshops, 100+ high-level speakers

With five plenary sessions and 12 interactive workshops, the conference covers a broad spectrum of discussions within the bioeconomy. For the first time, the IAC on Global Bioeconomy welcomes official partners from each continental region to strengthen the international character of the GBS. They are representing Japan, the ASEAN region, Eastern Africa, the European Union, and Latin America & the Caribbean.

The bioeconomy's role of solving global crises

More than 100 top-class speakers are taking part to discuss, among others, the bioeconomys role of solving global crises and effects of the corona crisis towards a sustainable bioeconomy as new economic strategy that stabilizes global economies. In the wake of pandemic, the global bioeconomy community will virtually come together for GBS2020 to explore uncharted territory and advance our sustainable development, Morakot Tanticharoen, Senior Advisor to the President of the National Science and Technology Development Agency Thailand (NSTDA). That Europe is willing to play its part in further establishing a biobased economy, is underlined by Peter Wehrheim, Head of Unit for the Bioeconomy and Food System at the European Commission:By scaling up its bioeconomy, the EU can become the first climate-neutral continent: I look forward to see many concrete best practice solutions for climate mitigation at this years Global Bioeconomy Summit.

However, speakers will not only refer to economy-driven potentials, but also will include social perspectives. The transition towards bio-based economies is not only about production but also about sustainable consumption. GBS2020 covers both sides of the equation and brings together experts from around the world to discuss regional differences in lifestyle and culture, says Torfi Jhannesson, Senior Adviser at the Nordic Council of Ministers. Top-class researchers such as Mary Maxon, Associate Laboratory Director for Biosciences, Lawrence Berkeley National Laboratory, will also contribute to the GBS. A vibrant bioeconomy is economic activity that is reinforced by the safe, secure, ethical and reciprocal use of biological data, as well as by international standards and norms in research and business operations, she says.

Communiqu and policy recommendations on how to further establish a sustainable bioeconomy

At the end of the virtual GBS conference week, a communiqu with policy recommendations developed and agreed by the International Advisory Council on Global Bioeconomy (IACGB) will be published and a shared vision on sustainable bioeconomy will be presented. For the first time the "Bioeconomy Youth Champions" will be chosen at the GBS. More than one hundred young bioeconomy players from all over the world have applied to take part in this competition, eight of which will be awarded and prepare their own Bioeconomy Roadmap.

Global expert survey and policy report results

The GBS will again provide the platform to present several international report results. The Global Expert Survey will shed light on sustainability governance for the bioeconomy and the Global Bioeconomy Policy Report summarizes again how countries across the globe have integrated bioeconomy into governmental action. According to this latest research, the trend of developing dedicated bioeconomy policy strategies has prevailed in recent years with 19 countries and macro-regions (Austria, Costa Rica, EU, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Malaysia, Nordic Countries, Norway, South Africa, Spain, Thailand, UK, US, East Africa)[1] having adopted strategies since 2010. In parallel, according to the authors, bioeconomy development is increasingly driven by the engagement of macro-regional and international actors as well as stakeholders from science, civil society and industry.

Industry, policy and science expertise represented

In addition, the GBS program will include different perspectives on bioeconomy innovations for the market and investment developments, for instance in the alternative protein area. Several high-level representatives from policy, science, business and industry will take part, among them the following:

Virtual exhibition on bioeconomy

A virtual world exhibition on bioeconomy will show how specific products can contribute to global sustainability goals. There is also a media corner again with books, games, teaching material and graphic novels on the subject of bioeconomy. In addition, GBS participants from all over the world present video clips about projects or ventures - from start-ups to large corporations.

Evening reception with food start-ups and guided tours in natural history museums

And the GBS participants don't have to do without an evening reception either: On 19th November, among other things, they can look forward to a guided virtual tour in natural history museums in Berlin, Germany, and Paris, France. In addition, an innovative bio-based food menu is virtually presented by the food start-ups CellFarm, Knaerzje, Solar Foods and Yoll.

Continued here:
1800+ experts will join the Global Bioeconomy Summit - European Biotechnology News

Generex Biotechnology Announces Interview with Richard Purcell EVP of R&D on the Yo! Dr.Yo Show with an Update on the Ii-Key COVID Vaccine Program -…

TipRanks

Were a little over one week past the Presidential election, and the market reaction shows that that investors are pleased. While the election margins were razor thin, the will of the voters came through: they rejected Donald Trump, and his brash, in-your-face style, but they also rejected the Democratic Party on policy; the Dems lost seats in the House, will likely not take control of the Senate, and also lost ground at the State level. Americas voters seem to be tired of drama, whether it comes from Donald Trump or the Democrats push to the political left. They want a government that will simply plod straight along.And it looks like they will get just that. With power split in the White House and the Chambers of Congress, were about to be reminded of a feature of the checks and balance system: that gridlock is a result of a closely divided electorate. Change wont happen unless one side or the other gets a large majority, or a small majority over several terms. Neither of those is in the cards for now.The immediate result is a multi-day market rally. The implication is clear the markets sentiment has calmed since the election, and investors look forward to government settling into a more normal mode in the coming months.To this end, investors are sure to find solid options in the near term. Writing from Raymond James, analyst Ric Prentiss has recently published three reviews on mid-cap stocks, pointing out why, in his view, they offer high return potential with more settled markets in the coming year. The stocks all fit a profile: they are at the lower end of the mid-cap range, with market valuations between $2 billion and $3 billion; they inhabit the telecom ecosystem, and they all have, according to Raymond James, over 80% upside potential. We ran the the three through TipRanks database to see what other Wall Street's analysts have to say about them.Telephone & Data Systems (TDS)First on our list, Telephone & Data Systems, is a Chicago-based company providing a range of telecom services to over 6 million customers. The company offers broadband over cable and wireline, wireless products and services, and TV and voice services. TDS operates the countrys fifth-largest cellular carrier.TDS has dramatically outperformed expectations in 2020, despite the ongoing coronavirus. Revenues, at $1.32 billion, are about level with the pre-corona report ($1.34 billion in Q4 2019), while earnings jumped in 1Q20 and have remained high ever since. The Q3 earnings, at 66 cents, beat the forecast by 153%. It was an impressive performance, made more so by the 266% year-over-year growth.On another bright note for investors, TDS has maintained its dividend payment through the year. The 17-cent per common share payout annualizes to 68 cents, and offers a yield of 3.6%, nearly double the average yield found among S&P-listed companies.TDS has shown strong business through the year, but its weak point has been in the fiber and wireline niche. However, Raymond James Ric Prentiss looks at the half-full glass, noting: "WFH policies have continued to result in some slower approvals from municipalities and electrical utilities associated with building aerial fiber. And in some cases, TDS is pivoting to alternatives with better economics. Still, TDS Telecom grew fiber service addresses 5% y/y and is seeing better-than-expected take rates around 30-40%, depending on the market. Moreover, 34% of Wireline customers are now served by fiber, compared to 29% a year ago, and TDS expects acceleration throughout the rest of 2020."Prentiss rates TDS as a Strong Buy, and increased his price target by 6% to $34. At that level, he sees an 81% upside for the stock over the next months. (To watch Prentisss track record, click here)This stock also holds a Strong Buy rating from the analyst consensus, based on 3 unanimous Buy reviews set in recent weeks. Shares are priced at $18.73 and the average target of $34.83 suggests a one-year upside of 85.5%. (See TDS stock analysis on TipRanks)ViaSat, Inc. (VSAT)Next up, ViaSat, is a high-speed satellite broadband provider. The California company serves commercial and defense markets, building on the broad need, across industries, for secure communications.Social lockdown measures took a toll on the companys business, especially the shutdowns of airlines. Commercial air traffic relies heavily on satellite communications, and that slowdown is still weighing on ViaSat.The headwinds are partially offset by a backlog in services ordered. Revenues have remained stable over the past four quarters, between $530 million and $588 million, with the $554 million recorded in Q3 being solidly in the middle of that range. Earnings have bounced back into positive territory after turning negative in Q2. The third quarter EPS was only 3 cents, but that was a dramatic sequential improvement from the previous 20-cent net loss.In his look at VSAT, Prentiss notes, Government Systems and Commercial Networks remain strong, while the IFC business continues to navigate significant headwinds related to COVID-19 On the positive side, social distancing and Safer-At-Home policies are driving more residential broadband data usage and pushing ARPUs higherPrentiss rates VSAT an Outperform (i.e. Buy) while his $63 price target suggests an 87% upside potential.Overall, ViaSat gets a Moderate Buy rating from the analyst consensus, based on 3 reviews that include 2 Buys and 1 Hold. The shares have an average price target of $53.33, which implies a 12-month upside of 59% from the trading price of $33.39. (See VSAT stock analysis on TipRanks)EchoStar Corporation (SATS)Last but not least is EchoStar, another satellite operator. This company controls a constellation of communications satellites, offering satcom capabilities to the media and private enterprises, as well as both civilian and military US government agencies. In addition, EchoStar provides satellite broadband in 100 countries around the world.At the top line, EchoStar's revenues have held steady for the past three quarters, coming in at $465 million, $459 million, and $473 million. And while earnings were negative in Q1 and Q2, the Q3 results showed a net profit of 26 cents per share.The sequential Q3 improvements at the top and bottom lines come along with increases in the EchoStars subscriber base, to more than 1.54 million in total. The company also boasts a strong balance sheet, having more than $2.5 billion in cash on hand and no net debt.Covering SATS, Ric Prentiss is upbeat about near- and mid-term prospects. He writes, SATS [has] strategic optionality in a time when others, especially higher levered satellite companies, are cash starved facing significant maturities or capex programs we think a number of organic and inorganic growth options are being considered, including the future deployment of SBand spectrum after lining up anchor tenant(s). Lastly, we believe EchoStar's recently announced collaboration with Inmarsat to provide capacity for In-Flight Connectivity should provide over time high margin cash flows, and we note the deal is not exclusive.These comments back another Strong Buy rating, and Prentisss $57 target price indicates room for 123% growth in the next year. In terms of other analyst activity, it has been relatively quiet. 1 Buy and 1 Hold ratings assigned in the last three months add up to a Moderate Buy analyst consensus. In addition, the $43.50 average price target puts the upside potential at ~74%. (See SATS stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Read the rest here:
Generex Biotechnology Announces Interview with Richard Purcell EVP of R&D on the Yo! Dr.Yo Show with an Update on the Ii-Key COVID Vaccine Program -...

PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update – Yahoo Finance

FLORHAM PARK, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Companys proprietary Versamune T-cell activating technology, today announced its financial results for the third quarter ended September 30, 2020 and provided a business update.

Third Quarter 2020 and Recent Business Highlights

Successfully raised approximately $19 million via a public offering of common stock.

Initiated VERSATILE-002, a Phase 2 trial of PDS0101, our investigational drug candidate, in combination with standard of care KEYTRUDA for first-line treatment of patients with metastatic or recurrent HPV-positive head and neck cancer.

Initiated a Phase 2 study of PDS0101 in combination with standard of care chemoradiotherapy at the MD Anderson Cancer Center for treatment of locally advanced cervical cancer.

Continued development of PDS0103 in partnership with the National Cancer Institute.

Advanced co-development program with Farmacore with plans to move the PDS0203 COVID-19 vaccine into clinical development with the support of the Brazilian government.

Expanded Board of Directors with appointment of preeminent oncologist, Otis Brawley, M.D.

As a result of our teams dedicated efforts during the third quarter and our clinical partnerships with leading institutions in immuno-oncology, today PDS0101 is being evaluated in three phase 2 clinical trials for multiple HPV-associated cancers, commented Dr. Frank Bedu-Addo, President and Chief Executive Officer of PDS Biotechnology. Furthermore, the successful equity raise we completed in August strengthened our balance sheet, ensuring we can continue to progress the clinical development of our oncology programs as well as expand both our oncology and infectious disease programs despite the challenges posed by the COVID-19 pandemic.

Third Quarter 2020 Financial Review

Story continues

For the third quarter of 2020, net loss was approximately $3.9 million, or $0.23 per basic share and diluted share, compared to a net loss of approximately $5.8 million, or $1.10 per basic share and diluted share for the third quarter of 2019.

Research and development expenses totaled approximately $2.1 million for the third quarter of 2020, compared to approximately $1.8 million for the same period in 2019, an increase of 12%. The increase was primarily attributable to an increase of $0.1 million in technical operations (manufacturing) and $0.3 million in clinical studies, offset by a decrease of $0.1 million in professional fees and $0.1 million in regulatory expenses.

For the third quarter of 2020, general and administrative expenses were approximately $1.8 million compared with approximately $3.0 million during the third quarter of 2019, a decrease of 40%. The decrease was primarily attributable to a decrease of $0.2 million in salary and benefits, $0.1 million in facilities and office expense, $0.3 million in insurance expense, $0.6 million in professional fees, and $0.1 million in legal fees offset by an increase of $0.1 million in licenses, taxes and fees.

Total operating expenses for the third quarter of 2020 were approximately $3.9 million, compared to total operating expenses of approximately $5.8 million during the same period of 2019, a decrease of 33%.

As of September 30, 2020, the Companys cash balance was approximately $33.5 million.

Conference Call and Webcast

The conference call is scheduled to begin at 8:00 am ET on Thursday, November 12, 2020. Participants should dial 877-407-3088 (United States) or 201-389-0927 (International) and mention PDS Biotechnology. A live webcast of the conference call will also be available on the investor relations page of the Company's corporate website at http://www.pdsbiotech.com.

After the live webcast, the event will be archived on PDS Biotechs website for 6 months. In addition, a telephonic replay of the call will be available for 6 months. The replay can be accessed by dialing 877-660-6853 (United States) or 201-612-7415 (International) with confirmation code 13712632.

About PDS Biotechnology

PDS Biotech is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Companys proprietary Versamune T-cell activating technology platform. Versamune effectively delivers disease-specific antigens for in vivo uptake and processing, while also activating the critical type 1 interferon immunological pathway, resulting in production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them. To learn more, please visit http://www.pdsbiotech.com or follow us on Twitter at @PDSBiotech.

Forward Looking Statements

This communication contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the Company) and other matters. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the Companys management, as well as assumptions made by, and information currently available to, management. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as may, will, should, would, expect, anticipate, plan, likely, believe, estimate, project, intend, forecast, guidance, outlook and other similar expressions among others. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the Companys ability to protect its intellectual property rights; the Companys anticipated capital requirements, including the Companys anticipated cash runway and the Companys current expectations regarding its plans for future equity financings; the Companys dependence on additional financing to fund its operations and complete the development and commercialization of its product candidates, and the risks that raising such additional capital may restrict the Companys operations or require the Company to relinquish rights to the Companys technologies or product candidates; the Companys limited operating history in the Companys current line of business, which makes it difficult to evaluate the Companys prospects, the Companys business plan or the likelihood of the Companys successful implementation of such business plan; the timing for the Company or its partners to initiate the planned clinical trials for its lead asset PDS0101 and other Versamune based products; the future success of such trials; the successful implementation of the Companys research and development programs and collaborations, including any collaboration studies concerning PDS0101 and other Versamune based products and the Companys interpretation of the results and findings of such programs and collaborations and whether such results are sufficient to support the future success of the Companys product candidates; the acceptance by the market of the Companys product candidates, if approved; the timing of and the Companys ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect to, the Companys product candidates; and other factors, including legislative, regulatory, political and economic developments not within the Companys control, including unforeseen circumstances or other disruptions to normal business operations arising from or related to COVID-19. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk factors included in the Companys annual and periodic reports filed with the SEC. The forward-looking statements are made only as of the date of this press release and, except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Media & Investor Relations Contact:

Deanne RandolphPDS BiotechnologyPhone: +1 (908) 517-3613Email: drandolph@pdsbiotech.com

Jacob GoldbergerCG CapitalPhone: +1 (404) 736-3841Email: jacob@cg.capital

PDS BIOTECHNOLOGY CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

September 30, 2020

December 31, 2019

ASSETS

(unaudited)

Current assets:

Cash and cash equivalents

$

33,468,935

$

12,161,739

Prepaid expenses and other

373,395

2,308,462

Total current assets

33,842,330

14,470,201

Property and equipment, net

9,345

21,051

Operating lease right-to-use asset

593,580

Total assets

$

34,445,255

$

14,491,252

LIABILITIES AND STOCKHOLDERS' EQUITY

LIABILITIES

Current liabilities:

Accounts payable

$

1,559,591

$

1,197,720

Accrued expenses

1,222,773

1,097,640

Restructuring reserve

498,185

Operating lease obligation - short term

116,240

Total current liabilities

2,898,604

2,793,545

Noncurrent liability:

Operating lease obligation - long term

521,692

STOCKHOLDERS' EQUITY

Common stock, $0.00033 par value, 75,000,000 shares authorized at September 30, 2020 and December 31, 2019, 22,261,619 shares and 5,281,237 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively

7,346

1,742

Additional paid-in capital

70,775,892

40,633,670

Accumulated deficit

(39,758,279

)

(28,937,705

)

Total stockholders' equity

31,024,959

11,697,707

Total liabilities and stockholders' equity

$

34,445,255

$

14,491,252

PDS BIOTECHNOLOGY CORPORATION AND SUBSIDIARIES

Read more:
PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update - Yahoo Finance

Global Separation Systems for Commercial Biotechnology Industry Outlook and Growth Forecast for the Period 2020 to 2026 :, Thermo Fisher Scientific,…

The Separation Systems for Commercial Biotechnology Market research report is a detailed analysis of the latest developments, market size, status, future technologies, industry drivers, challenges, regulatory guidelines, and the top corporate profiles and player strategies. Research studies give an overview of the Separation Systems for Commercial Biotechnology market is a valuable guidance and guidance tool for companies and individuals interested in predicting the market size by obtaining key statistics based on manufacturers market conditions. Get the report and understand the structure of the details (full index, list of tables and figures, figures).

Download Free Sample Copy of Separation Systems for Commercial Biotechnology market Report:https://www.worldwidemarketreports.com/sample/350683

Detailed qualitative analysis includes identification and investigation of aspects such as market structure, growth drivers, constraints and challenges, new product trends and opportunities. The report also looks at the financial condition of large companies, including gross profit, revenue generation, sales volume, revenue, cost of sales, individual growth rates, and other financial indicators. Basically, the report provides details on all the major market players such as market trends, growth drivers, constraints, opportunities, challenges, future prospects, and , Thermo Fisher Scientific, GE Healthcare, Agilent Technologies;Shimadzu Corporation, bioM rieux SA, Bio-Rad Laboratories, Inc., Hitachi Koki Co., Ltd., Merck & Co., Inc., QIAGEN, WATERS, Sartorius, PerkinElmer, Inc., Danaher, Miltenyi Biotec, BD,.

The Separation Systems for Commercial Biotechnology market is analyzed with a combination of irreplaceable primary knowledge and secondary sources and the best combination of internal methodologies. Real-time market valuation is an important part of market size and forecasting methods. Our panel of industry experts and key participants helped to summarize the relevant aspects using realistic parameter estimates for a comprehensive study.

Factors contributing to the growth of the Separation Systems for Commercial Biotechnology market include an increasing demand for automated solutions, and the need to meet regulatory and efficiency requirements. Additionally, the growing demand for Separation Systems for Commercial Biotechnology and its growing importance in developing countries provide opportunities for market growth.

The report has key sections such as Type and End User along with various segments that determine the outlook for the global Separation Systems for Commercial Biotechnology market. Each type provides data on respect for the business during a speculative period. The application area also provides information on the volume and consumption during the estimated period. Understanding this segment will help readers to recognize the importance of variables that influence market development.

Listed Types are, Microarray, Lab-on-a-chip, Biochip, Magnetic separation, Chromatography, Flow cytometry, Membrane filtration, Electrophoresis, Centrifugation,

Listed Application/ End-Use are, Pharmaceutical, Food & Cosmetics, Agriculture, Others,

Geographically, the market is divided into the major regions of the world, providing a comprehensive analysis of consumption, sales, and market share for the period 2020-2026. Regional divisions include North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Currently, the report analyzes changes in market dynamics and demand patterns related to the COVID-19 epidemic. This report provides a detailed view of business areas, growth prospects, and future prospects based on the impact of COVID-19 on the growth of the entire industry. The report also includes a post-COVID-19 outlook and analysis of the current and future impact of pandemics on the market.

Get the Free Covid-19 Impact Analysis, And All upadates on Separation Systems for Commercial Biotechnology Industry:https://www.worldwidemarketreports.com/covidimpact/350683

Competitive Landscape-

The competitive analysis is one of the best sections of the report, comparing the progress of key players based on key parameters such as market share, new developments, global reach, regional competition, pricing, and production. From the nature of the competition to future changes in the vendor environment, the report provides a detailed analysis of the competition in the global Separation Systems for Commercial Biotechnology market.

Key questions answered in the report:

Thanks for your visit. If you have any other questions, please contact us. Our team will prepare a report tailored to your needs.

https://www.worldwidemarketreports.com/quiry/350683

Contact Us:

Mr. ShahWorldwide Market ReportsSeattle, WA 98154,U.S.Email: [emailprotected]

The rest is here:
Global Separation Systems for Commercial Biotechnology Industry Outlook and Growth Forecast for the Period 2020 to 2026 :, Thermo Fisher Scientific,...

PDS Biotechnology Corporation (PDSB) revealed pretty balanced Earnings results as it emphasizes cost-cutting measures – The News Heater

Thursday, November 12, 2020, A company in the biotech sector PDS Biotechnology Corporation (Nasdaq: PDSB), publicized its quarterly results for the period ended 30 September 2020 and provided a business update.

Net losses were almost $3.9 million for the third quarter of 2020, or $0.23 per basic share and diluted share, compared to a net loss of approximately $5.8 million for the third quarter of 2019, or $1.10 per basic share and diluted share.

Learn from the #1 Futures Trading Education Institute in the World

Learn a direct approach to trading Futures that provides you with the techniques and the confidence you need to make consistent profits.

***For a limited time, we are offering a FREE CLASS. Dont take our word for how effective our teaching methods are see it for yourself!

Sign up today to receive free access and a guided tour through our program, PATH TO SUCCESS.

Sponsored

For the previous quarter, R&D costs reached about $2.1 million, in contrast to $1.8 million at the same time in 2019, an improvement of 12 percent. The rise was mainly due to an increase in tech addition to operations of $0.1 million and clinical trials of $0.3 million, counterbalanced by a decline in professional fees of $0.1 million and regulatory expenses of $0.1 million.

General and administrative expenses were roughly $1.8 million for the period compared to $3.0 million years over year, which was a decline of 40 percent. The drop was largely due to a $0.2 million cut down in salaries and benefits, $0.1 million in expenditures for services and offices, $0.3 million in insurance costs, $0.6 million in professional fees, and $0.1 million in legal fees, offset by a rise in permits, taxes, and fees of $0.1 million.

Expenses related to the operation were almost $3.9 million for the third quarter, in comparison with total operating expenses of $5.8 million during the same quarter year before, which was a 33 percent decline.

The clinical-stage immunotherapy company that develops novel cancer therapies and medications for transferrable diseases based on the companys patented activating technology Versamune T-cell. Its cash balance was recorded $33.5 million as of September 30, 2020.

PDS Biotechnology Corporation (Nasdaq: PDSB) shares were trading 1.94% away from the 20-day Simple Moving Average. Its last months performance was recorded -9.73% in contrast with the 6 months performance of 151.38%.

See the original post:
PDS Biotechnology Corporation (PDSB) revealed pretty balanced Earnings results as it emphasizes cost-cutting measures - The News Heater

The Chart for Vir Biotechnology Inc. (VIR) Is Flashing Mixed Signals – The News Heater

Vir Biotechnology Inc. (NASDAQ:VIR) went down by -21.36% from its latest closing price compared to the recent 1-year high of $75.00. The companys stock price has collected -17.01% of loss in the last five trading sessions. Press Release reported on 11/06/20 that Vir Biotechnology Publishes New Research Characterizing Variation in the SARS-CoV-2 Spike Protein and Virulence of a Prevalent Immune Evasion Variant, N439K

Opinions of the stock are interesting as 5 analysts out of 8 who provided ratings for Vir Biotechnology Inc. declared the stock was a buy, while 0 rated the stock as overweight, 2 rated it as hold, and 0 as sell.

Learn from the #1 Futures Trading Education Institute in the World

Learn a direct approach to trading Futures that provides you with the techniques and the confidence you need to make consistent profits.

***For a limited time, we are offering a FREE CLASS. Dont take our word for how effective our teaching methods are see it for yourself!

Sign up today to receive free access and a guided tour through our program, PATH TO SUCCESS.

Sponsored

The average price from analysts is $54.14, which is $29.49 above the current price. VIR currently public float of 109.06M and currently shorts hold a 6.92% ratio of that float. Today, the average trading volume of VIR was 1.14M shares.

VIR stocks went down by -17.01% for the week, with a monthly drop of -37.61% and a quarterly performance of -51.56%, while its annual performance rate touched 84.45%. The volatility ratio for the week stands at 9.43% while the volatility levels for the past 30 days are set at 7.52% for Vir Biotechnology Inc.. The simple moving average for the period of the last 20 days is -28.59% for VIR stocks with a simple moving average of -30.02% for the last 200 days.

Many brokerage firms have already submitted their reports for VIR stocks, with BofA Securities repeating the rating for VIR by listing it as a Buy. The predicted price for VIR in the upcoming period, according to BofA Securities is $55 based on the research report published on October 05th of the current year 2020.

Goldman, on the other hand, stated in their research note that they expect to see VIR reach a price target of $54, previously predicting the price at $48. The rating they have provided for VIR stocks is Buy according to the report published on September 14th, 2020.

JP Morgan gave a rating of Neutral to VIR, setting the target price at $29 in the report published on September 11th of the current year.

After a stumble in the market that brought VIR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.99% of loss for the given period.

Volatility was left at 7.52%, however, over the last 30 days, the volatility rate increased by 9.43%, as shares sank -41.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -38.74% lower at present.

During the last 5 trading sessions, VIR fell by -17.01%, which changed the moving average for the period of 200-days by +2.97% in comparison to the 20-day moving average, which settled at $34.83. In addition, Vir Biotechnology Inc. saw 102.86% in overturn over a single year, with a tendency to cut further gains.

Reports are indicating that there were more than several insider trading activities at VIR starting from Parrish Jay, who sale 6,944 shares at the price of $31.27 back on Nov 02. After this action, Parrish Jay now owns 222,222 shares of Vir Biotechnology Inc., valued at $217,153 using the latest closing price.

Virgin Herbert, the EVP, Research & CSO of Vir Biotechnology Inc., sale 3,805 shares at $35.04 during a trade that took place back on Oct 27, which means that Virgin Herbert is holding 23,700 shares at $133,335 based on the most recent closing price.

Current profitability levels for the company are sitting at:

The net margin for Vir Biotechnology Inc. stands at -2158.98. The total capital return value is set at -62.52, while invested capital returns managed to touch -62.97. Equity return is now at value -81.10, with -42.30 for asset returns.

Based on Vir Biotechnology Inc. (VIR), the companys capital structure generated 0.27 points at debt to equity in total, while total debt to capital is 0.27. Total debt to assets is 0.22, with long-term debt to equity ratio resting at 0.21. Finally, the long-term debt to capital ratio is 0.21.

When we switch over and look at the enterrpise to sales, we see a ratio of 119.29, with the companys debt to enterprise value settled at 0.00. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.81.

Outsmart Wall Streets Top Options Traders

Its no secret that the market has provided endless opportunities to generate extremely profitable trades this past quarter. Scott Bauer, a professional trader with 25+ years of experience has already been targeting numerous triple-digit wins like these this year aloneHes actually put together a free guide that has 25 winning option strategies.

Click here to access the Options Profits Trading Guide now.

Sponsored

See original here:
The Chart for Vir Biotechnology Inc. (VIR) Is Flashing Mixed Signals - The News Heater

Franklin Square community raises money for mother with breast cancer – liherald.com

In just two days, an online fundraiser to help a Franklin Square mother with her cancer treatment had surpassed its goal of $100,000.

It has been such an emotional rollercoaster, and these two days really took me back to every person Ive crossed paths with in basketball, life, elementary school and I was in awe at the countless messages that began with You dont know me, but, Margaret Elenis posted as an update on her GoFundMe on Oct. 28, adding that it is such a beautiful feeling to know I have an army behind me.

At the age of 28, with a new husband and a new baby, Elenis was diagnosed with Stage 2B breast cancer. Her family spent thousands of dollars covering integrative medicine treatment, and by her 29th birthday, she was in remission.

She then decided to dedicate her life to teaching, educating and spreading awareness about healthy lifestyles, and opened a wellness and holistic center in Garden City in February 2020, after quitting her job as a teacher in New York City. Unfortunately, only three weeks later, she had to close it down due to the coronavirus pandemic.

Then, in April, Elenis found out she was pregnant with her second child. Shortly thereafter, she began to experience severe pains, and at five-and-a-half months pregnant, a doctor told her that he had found cancerous lumps in her bones, lungs and liver.

That same week, Elenis also contracted Covid and a staph infection that would not allow her wounds to hear, and would destroy her immune system. Due to the severity of her cancer, she had to give birth to her son at just 30 weeks.

He has since gained a pound in the newborn intensive care unit, where he remains to this day, while his mother tries to recover.

Elenis said she is so impressed by her son, but her treatments cost an average of three to four thousand dollars a week. Insurance does not cover it, which is why she needs help financially.

But still, she said, she remains positive that she will get better, as Franklin Square community members had raised $122,000 for her medical bills.

Continue reading here:
Franklin Square community raises money for mother with breast cancer - liherald.com

The Mental Health Advice We All Need Right Now – 5280 | The Denver Magazine

Photo by Milan Popovic on UnsplashHealth

It's been a quite a week and an extraordinary year. If you're feeling anxious, know you're not alone. We asked the experts to share practical tips for how to cope in these difficult times.

This year has put all of us through the emotional wringer. And if youre struggling to cope with it all, well, youre not alone.

A report released in October by the American Psychological Association revealed nearly one in five adults (19 percent) believe their mental health is worse than this time last year. Unfortunately, that percentage may only increase in the coming months as the pandemic continues to worsen in Colorado and across the country.

Were forecasting a rough mental health winter for a lot of people, says Justin Ross, clinical psychologist at the UCHealth Integrative Medicine Center in Central Park. The good news: There are simple steps we can take to make 2020 (and beyond) feel a bit more bearable. We asked Ross and two other local mental health experts how Coloradans can best cope.

If you or someone you know is in immediate crisis, call Colorado Crisis Services at 1-844-493-8255, or text TALK to 38255.

Feel your feelings. Then, track them. First things first: Give yourself permission to feel crappy right now. What were feeling is completely normal and 100 percent human, explains Ross. Were supposed to be anxious and upset and scared and sad when our lives are disrupted on such a high magnitude. Its also important to label what youre feeling, he adds, as doing so can lessen the intensity of your emotions and provide the space you need to actually deal with them. Saying something as simple as Im noticing Im feeling anxious is a good place to start.

From there, pay close attention to your daily thoughts and actionsa process Ross describes as tracking and for which there are appsto see if you can correlate behavioral habits with mood and thus make tweaks to your routine as needed. Its imperativeespecially as we enter a colder, darker season, that were paying really close attention to maintaining healthy thoughts and healthy daily behaviors, he says.

Accept what you cant control. A big reason for our collective anxiety right now is that many stressorsthe pandemic, the election, the recessionare out of our control. And while these circumstances are undoubtedly undesirable, saying things like This is so awful and I cant cope isnt going to help. In fact, that rhetoric will probably make you feel worse, says clinical psychologist Antonia Pieracci, PhD, co-founder of CBT Denver. Instead, try to accept the stressors that are out of your influence (like the fact that we dont know when the pandemic is going to end) and redirect your energy to things you can control (for example, goals you want to accomplish in the upcoming months). Doing so will help you feel empowered and like youve regained agency over your life.

Practice gratitude. Theres a lot of strong research that shows practicing gratitude can enhance your well-being, says Jenn Leiferman, PhD, director of the Rocky Mountain Prevention Research Center and a founder of the Population Mental Health and Wellbeing Program at the Colorado School of Public Health. This isnt about donning rose-colored glasses, but instead involves reflecting on whats going well in your world as a way to shift into a more positive mindset. Simple gratitude exercises, like listing three things youre grateful for everyday, can be really powerful, says Leiferman.

Find safe ways to connect. Social interaction is critical to our health. We need other people to function well, to survive, says Pieracci, referencing research that shows people who have active social lives live longer, are at less risk for dementia, and have better physical and mental health. Connectedness helps protect us during times of uncertainty, adds Leiferman, so its important to stay in regular touch with your community right now. If in-person get-togethers arent possible because of the pandemic, schedule weekly phone calls, commit to regular Zoom dates, or keep in touch the old-fashioned way by sending letters and photos in the mail. Even going for a walk and smiling at passersby can help, says Pieracci.

Try something new. Feeling despondent? Start a new hobby that engages your brain, suggests Pierraci. Doing something novel like learning a new language or practicing a new sport can help redirect your attention in a healthy way. It will also keep things feeling fresh and give you something to focus on in the months to come, adds Ross.

Meditate. Meditation, Ross explains, can help alleviate the physiological symptoms of anxiety, which include elevated heart rate, rapid breathing, and surges of adrenaline and cortisol. Meditation can also help reorient your thoughts, he adds. Dont know how to meditate? Learn with an app. Ross recommends Headspace, Calm, 10 Percent Happier, and Insight Timer (on which he is an instructor).

Limit doom scrolling. Its important to stay informed on whats going on in the world, but constantly consuming the news can increase feelings of hopelessness, says Pieracci. To strike a healthy balance, set both a time and a source limit for your social media consumption, suggests Ross. For example, commit to spending just five minutes every hour on social media and visit just two platforms during that time.

Get outside. Spending time in nature can be very therapeutic, and you dont need to drive anywhere to get your fix, says Leiferman. Go on a walk in your neighborhood, visit a local park, or simply sit in your backyard. While youre there, Leiferman suggests asking yourself: What are two things Im hearing right now? Two things Im seeing? Two things Im smelling?Turning your attention to your senses can help clear anxious thoughts and center your mind in the moment.

Exercise and practice basic self-care. Protect your well-being this winter by exercising, eating healthy, limiting alcohol consumption, and getting enough sleep, says Leiferman. Exercise, in particular, can have a powerful effectPieracci cites a 2019 study published in Depression and Anxiety that concluded exercising in any form for three hours a week may lower risk of depression. So if you find your mood dipping, sneak in some movement. It neednt be a full-blown workout; small bursts of activity, like jogging up and down your stairs a couple times, walking your dog an extra mile, or having a dance party in your kitchen, can make a difference.

Weve all been a little (or a lot) on edge this year. But if your mental health has tanked to the point where its interfering with relationships or your ability to perform your job or complete school work, seek professional help, advises Pieracci. You should also talk to someone if you feel like youre suffering so much internally that youre barely able to hold things together, she adds. Yet another sign you should connect with a pro is if your mental health has notably nosedived and you just cant seem to get back to normal, says Ross.

Not sure where to turn? Consider Energize Colorado, an organization that contracts with therapists (including Pieracci) to offer free and low-cost therapy sessions to people who would not otherwise be able to afford such services right now. Their website also contains links to mental health support groups, a directory of Colorado-based mental health professionals, educational resources, and more. The Happiness Trap is another online resource with free mental health videos and resources, says Pieracci. And the Colorado School of Public Healths Population Mental Health and Wellbeing website, recommended by Leiferman, contains educational content and links to community resources.

Continued here:
The Mental Health Advice We All Need Right Now - 5280 | The Denver Magazine

Ken Wallston, prominent nursing researcher and health psychology pioneer, has died – Vanderbilt University News

Ken Wallston

Professor of Nursing, Emeritus, Kenneth A. Wallston, regarded internationally as one of the founders of health psychology, died in Asheville, North Carolina, on Oct. 27. He was 78.

A faculty member at the Vanderbilt University School of Nursing for more than 40 years, Wallston worked widely in the transdisciplinary arena termed behavioral medicine. He was known for his research regarding how individuals beliefs in their ability to control their health influence their health behavior and outcomes. In the 1970s, he and colleagues developed the Multidimensional Health Locus of Control (MHLC) scales, which are still used to assess belief and health status.

In addition to his appointment at the School of Nursing, Wallston was a professor of psychology in the College of Arts and Science and professor of psychology and professor of human and organizational development at Peabody College of education and human development. During his decades at Vanderbilt, he was also a Kennedy Center member, research associate at the Vanderbilt Institute for Public Policy Studies, and longtime director of the VUSN Health Care Research Project. He was also an active member of the Institute for Medicine and Public Health at Vanderbilt University Medical Center.

Kens work spanned different academic disciplines and made an impact on students in multiple schools. He truly embodied Vanderbilts collegial trans-institutional culture, said Linda D. Norman, School of Nursing dean and the Valere Potter Menefee Professor of Nursing. Throughout his distinguished career, he engaged many, many students and faculty in his research projects.

Dr. Russell Rothman, the Ingram Professor of Integrative and Population Health at the School of Medicine and director of the Institute for Medicine and Public Health, recalled Wallstons scholarship and collaborative nature. Ken was a tremendous scholar who was instrumental in expanding our understanding of social and behavioral determinants of health, Rothman said. His work on how individuals perceive their health and how this impacts their health behavior is a fundamental component to research that we do across the Vanderbilt Institute of Medicine and Public Health. He played numerous valuable roles across the institute, providing valuable mentorship and research collaborations to advance our understanding of individual and population health.

In addition to his research, Wallston taught research and statistics in the Nursing Schools masters and Ph.D. programs. Born in Stamford, Connecticut, Wallston earned a bachelors degree in psychology from Cornell University before obtaining his master of arts and doctorate in social psychology from the University of Connecticut. After several years as assistant professor and researcher at the University of Wisconsin, he joined Vanderbilt as assistant professor in the School of Nursing and College of Arts and Science in 1971. He was appointed full professor in 1982. Wallston served on a variety of school and university committees, including chairing the universitys Faculty Senate. He earned many professional and Vanderbilt awards, and was named the Joe B. Wyatt Distinguished University Professor in 2007. He was appointed professor of nursing, emeritus, upon his retirement in 2017.

A prolific researcher, Wallston published hundreds of articles during his career and continued in retirement. He was named fellow by both the American Psychological Association and Society of Behavioral Medicine.

Those who knew Wallston talk about his collegial spirit. Ken was my teacher, mentor, colleague and friend for over 40 years. He generously shared his expertise, experience, and personal passion to discover things that made a difference in peoples lives, said School of Nursing Professor Melanie Lutenbacher. Ken influenced the development and work of thousands of students and researchers from multiple disciplines around the world. The lives of countless patients with chronic illnesses have been improved because of his work and influence.

Wallston is survived by his wife, Jonatha Gibaud, and two children, Margot Wallston and Joel Atyas.

A virtual memorial service will be held Sunday, Dec. 13. In lieu of flowers, the family requests gifts be directed to the Ken Wallston Community Speaker Fund at Brevard Jewish Community, 235 Camptown Road, Brevard, North Carolina 28712. The family also requests photos, written notes and stories for a tribute on mykeeper.com. Contact the family at kwallstonmemorial@gmail.com if you wish to attend the service, contribute to his memorial page, have questions about the speaker fund or wish to send personal messages.

More here:
Ken Wallston, prominent nursing researcher and health psychology pioneer, has died - Vanderbilt University News

Functional fungi: why mushrooms are the winter wellness trend to try – Evening Standard

A

s we prepare to head into the deepest darkest depths of winter, many of us will endeavour to look after ourselves better, what with flu season and the colder weather - throw in a global pandemic and its no surprise were all searching for something to get us through the next few months with our immune systems still intact and stress levels at bay.

The latest hype? Shrooms. No, not that type, medicinal mushrooms, also known as functional mushrooms, are having a moment - and the likes of Elle Macpherson and Gwyneth Paltrow add them to everything from their morning lattes to protein shakes.

Functional fungi is even making its way into craft beer and face serums - so do they deserve a space in your winter wellness toolkit?

Mushrooms have long been used in Asia for their ability to improve health, maintain vitality, preserve a youthful appearance, and to counter the adverse health effects of chronic stress, says integrative medicine specialist Dr Andrew Weil. Research also demonstrates that a variety of traditional mushrooms possess anti-bacterial, anti-viral and immune-enhancing properties.

Are all mushrooms created equal? All mushrooms are good for us and contain beneficial levels of antioxidants and other plant chemicals, offers Grace Kingswell, a nutritional therapist specialising in functional medicine, but those called 'medicinal' simply have greater levels.

Its still worth eating a diet rich in the brown paper bag variety, even the common white button mushroom has immune-modulating properties, says Martin Powell, mycologist and author of Medicinal Mushrooms. While Dr Weil points to oyster mushrooms, which contain compounds that can help address high cholesterol.

When it comes to the so-called medicinal kind, some, like shiitake and maitake, can be found on supermarket shelves. The shiitake mushroom is a personal favourite, it appears to enhance immunity and may reduce the risk of several types of cancer, Dr Weil says. Maitake contains complex sugars called beta-glucans that have immune-enhancing effects.

Others, like lions mane, reishi, cordyceps and chaga, are more commonly found in supplement form, as they are considered less edible due to their woody or bitter taste.

This special class of fungi is also believed to have adaptogenic properties, along with herbs such as ashwagandha and ginseng, which are thought to help the body deal with stress and balance hormones. Adaptogenic mushrooms have the ability to modulate stress hormones from our adrenal glands and regulate the functioning of our immune system," says Tom Smale, co-founder of London-based functional food brand Wunder Workshop."

Shrooms to know

The use of reishi has been recorded for over 2,000 years in China, say Patricia Lopez, founder of the London Academy of Healing Nutrition, and Nam Singh-Tao Shi, a San Francisco-based TCM practitioner and faculty member of the school: It contains bioactive components as well as antioxidant properties that enhance the immune system. It has also been deemed the mushroom of immortality as it is believed to enhance longevity.

Reishi also helps to regulate sleep patterns and achieve homeostasis balance in our system and is an ideal year-round daily supplement, offers Smale.

Chaga is known as the king of mushrooms and is very high in antioxidants," Smale continues. It also contains the beta glucan-rich polysaccharides giving it potent immune supporting properties.

Cordyceps is deemed a kidney and lung tonic in Traditional Chinese Medicine (TCM), explains Lopez, it is best known to support improved stamina and studies have backed its ability to support athletic performance.

Smale agrees, suggesting adding a teaspoon to coffee 30 minutes before exercise to help your body deal with training stress. Cordyceps has been proven to increase aerobic capacity and respiratory function and help with oxygen flow in the brain, he says.

Lions mane is typically taken to support nerves and brain function, Powell says, it may help to promote focus and energy.

Healing (and warming) elixirs

So, how best to reap all of these benefits? When buying supplements, look for organic and wild-foraged mushroom sources, advises Lopez, who suggests adding them to warm elixirs, stews, sauts, or porridge to promote better digestion.

Wellness types are increasingly spiking their morning coffees with shrooms, too. Wunder Workshops Superior Chaga (25) is sustainably wild-harvested from birch trees in the Greater Khingan Mountains in northeast China and dual-extracted, a process which removes the fibrous proteins from the mushroom to give better access to the nutrients. Its the perfect coffee substitute in terms of flavour or you can add it to your coffee for faster absorption. Equally mix it with hot water and a bit of milk, and its not too dissimilar to your regular cup of tea," Smale says.

Glow Bar now sells a variety of mushroom powders, including coffee alternative chaga-ccino (30, glowbar.co.uk), which blends wild chaga and raw cacao, for a mocha with a difference. The brand advises you consult with a doctor before using its products if you are on any medications or are undergoing medical treatment.

Bottoms up

Cutting down on booze? Fungtn, a new alcohol-free craft beer brand born out of the first lockdown, has launched the UKs first range of 0.5% ABV lagers and IPAs brewed with functional mushrooms, including lions mane, reishi and chaga (18/case of six, fungtn.com). The brand says its tapping into the new wave of mindful drinkers - and the addition of myco adaptogens apparently enhances the depth, body and mouthfeel of the beer without the need for additives commonly used in non-alcoholic beers.

Super-charged skincare

Beauty buffs are also getting in on the shroom action. Dr Weil teamed up with Origins to create the brands now best-selling Mega-Mushroom Relief & Resilience range which features products designed to nourish the skins natural barrier and soothe inflamed skin - one bottle of the Soothing Treatment Lotion (32, origins.co.uk) is sold every eight seconds. Studies on several unique mushroom species show promising anti-inflammatory effects, and the topical use of anti-inflammatory mushrooms may help protect the skin against damage from environmental stressors, Dr Weil says.

Meanwhile, snow mushroom, also known as tremella fuciformis, is another fungus-derived active ingredient making its way onto your shelfie. It acts in a similar way to hyaluronic acid to quench parched skin, lock in moisture and support healthy ageing. Try Volitions Snow Mushroom Water Serum (52, cultbeauty.co.uk) or The Inkey Lists jelly-like Snow Mushroom Moisturiser (9.99, boots.co.uk).

Time to shroom-charge your winter wellness? Anythings worth a shot at the moment.

Read this article:
Functional fungi: why mushrooms are the winter wellness trend to try - Evening Standard

Yes, Gas Can Cause Chest Pain Here’s What You Need to Know – POPSUGAR

A burp is a common sign that you're, well, experiencing some gas. Chest pain, on the other hand, is a gas symptom that's way less discussed.

"Gas can cause more than just pain in the belly. Gas can be described as a stabbing pain or tightness in the chest, which mimics chest pain," Dr. Monisha Bhanote, MD, FCAP, an integrative medicine physician, said.

According to Dr. Bhanote, gas is created in the body two ways: by swallowing air and through the digestive process.

When one eats or drinks too quickly, they can swallow air, which may lead to gas accumulation in the stomach; so, eating slower could help, she explained.

As for digestion, Dr. Bhanote said that not all of the sugar, starch, and fiber one consumes is broken down in the small intestine. It passes onto the large intestine, where bacteria further breaks it down into carbon dioxide, oxygen, nitrogen, hydrogen, and methane, which eventually leaves the body.

"Certain foods may also increase gas in individuals. This varies based not only on the food but on the bacterial colonization of the individual's gastrointestinal tract. Common culprits may include cruciferous vegetables, such as broccoli and cabbage [and] whole grains, as well as dairy products, soft drinks, beans, and some fruits."

Those experiencing chest pain should always consult a doctor about a diagnosis and treatment Dr. Bhanote stressed this if your gas is persistent and severe enough to affect your daily activities or cause changes in bowel movements, constipation, diarrhea, nausea, vomiting, or bloody stools. And if you're experiencing prolonged abdominal or chest pain that is out of the ordinary, Dr. Bhanote said to seek immediate care.

One topic worth discussing with your doctor is how to reduce gas by adjusting your eating habits. Dr. Bhanote suggested exploring possible food intolerances and eliminating unnecessary contributors to gas production, like carbonated beverages and sugar substitutes.

Slowing down when eating, avoiding drinking through a straw, and passing on chewing gum are easy ways to avoiding swallowing access air, she added.

And if you're unable to prevent gas from building up, there are some holistic approaches you can take (with a doctor's permission!) to feel better.

"Some herbal teas can aid in the digestive process and reduce gas. These may include any combination of ginger, peppermint, chamomile, or anise."

Additionaly, you can drink a glass of water with added apple cider vinegar before a meal to help prevent gas and bloating, Dr. Bhanote said. Getting active after a meal can also help by moving nutrients through your body more efficiently.

Click here for more health and wellness stories, tips, and news.

Follow this link:
Yes, Gas Can Cause Chest Pain Here's What You Need to Know - POPSUGAR

A rising interest in thousands of years old Indian medical system – Korea Times

The following article was contributed via the Embassy of India in Korea as part of its efforts to promote Ayurveda, a natural system of medicine, originated in India more than 3,000 years ago. ED.By Song Han-youngIn recent years, mega-trends such as "naturalism" and "chemical-free" have continued around the world. These trends naturally led to interest in natural herbs which resulted in a gradual increase of herb-related products. In addition, as concerns on "immunity" and "health" increased during the coronavirus outbreak this year, interest in "how can I keep my usual health?" contributed to "What could protect my health?" The situation affected and raised interest in natural herbs.In recent years, mega-trends such as "naturalism" and "chemical-free" have continued around the world. These trends naturally led to interest in natural herbs which resulted in a gradual increase of herb-related products. In addition, as concerns on "immunity" and "health" increased during the coronavirus outbreak this year, interest in "how can I keep my usual health?" contributed to "What could protect my health?" The situation affected and raised interest in natural herbs.

In Korea, the term "medicinal herb" is more familiar than "natural herb." And when it comes to medicinal herbs, people naturally think of Oriental or Chinese medicine. But the West is more familiar with Ayurveda. In fact, according to the business report, "Future Market Insight 2017," 57.8 percent of the herbal drug market is Ayurvedic products. This means that Ayurveda acquires more than half of the global herb market. According to Google Trend Search, the search volume of Ayurveda is more than four times higher than that of Chinese medicine. The gap is gradually growing. This also implies that Ayurveda is better-known worldwide than Chinese medicine.The easiest way to describe Ayurveda is as Indian traditional medicine. Just as there is Korean medicine in Korea and Chinese medicine in China, India also has its own traditional medicine, which is called Ayurveda. Although there are differences of opinion among scholars, it is generally said that Ayurveda has a history of about 5,000 years. This means that it almost coincided with the Indus civilization, and the history of Ayurveda is understood that it is an accumulated medical knowledge obtained by ancient people observing nature.The important point is that traditional medicine with a long history has been actively used as one of the medical systems in India and its surrounding cultures to this day. The medical system has the characteristic that it can be maintained and inherited only if it has a practical effect. In other words, it means that the knowledge of Ayurveda survived through the clinical trials for a long time.In recent years, Western medicine is used as a synonym for modern medicine and is becoming the center of the situation, but gradually people are recognizing there are some areas that Western medicine cannot handle. As a result, the concept of "integrative medical science" including other medical systems began to develop. In particular, the medical system which has a long history like Ayurveda and has been widely used in one culture to this day is receiving a lot of attention because it has been historically verified.Interest in Ayurveda is increasing gradually in Korea as well as in the West. "Oil pulling" and "coffee mixed with coconut oil or butter" which is a trend these days, are based on Ayurvedic health methods. In addition, a Korean corporation has recently developed Ayurveda-based lifestyle products, and small and medium-sized enterprises are also launching products with Ayurveda concepts one by one.Growing interest in Ayurveda from global trends to medical systems and real-life products signifies that awareness of Ayurveda is being raised in Korea. We look forward to the day when the "holistic health method" handled by Ayurveda will also shine in Korea.

Song Han-young is an Ayurvedic doctor and CEO of Veda Life (Apoveda).

Originally posted here:
A rising interest in thousands of years old Indian medical system - Korea Times

Pro Active Physical Therapy & Sports Medicine Opens a New Clinic in Brighton – Insurance News Net

CARLSBAD, Calif., Nov. 10, 2020 /PRNewswire/ --Physical Rehabilitation Network (PRN) of Carlsbad, Calif., a leading physical therapy provider and practice management organization, today announced the grand opening of its affiliated Pro Active Physical Therapy & Sports Medicine (Pro Active) clinic inBrighton, Colo.,located at 1321 South. 4th Ave. The Pro Active Brighton clinic elevates the brand's presence in the state to 13.

Pro Active's new outpatient clinic will support all ages and is proud to offer theBrighton communityand surrounding areas a full range of pain management and injury prevention services including: physical therapy, functional integrative therapy, work injury rehabilitation, blood flow restriction therapy and sports medicine for a combined approach to pain resolution and injury recovery.

"The opening of our Brighton clinic is another critical step toward our commitment to expand access to quality physical therapy care across the state of Colorado," said Ajay Gupta, CEO, PRN. Led by Kate Farner, we have assembled an extremely talented, experienced and passionate team at the Brighton location, who are proud to not only offer high-quality care but provide a safe and rewarding experience for patients seeking care."

Clinic partner, [Kate] Farner, PT, DPT, ATC, will oversee the new Brighton location. A native of the California desert, Farner moved to northern Colorado in 2003 after receiving her Bachelor of Science degree in Exercise Science (Athletic Training) from the University of Northern Colorado in 2006. Farner also has a Doctorate of Physical Therapy from Regis University.

Farner is a Licensed Physical Therapist and Certified Athletic Trainer specializing in the treatment of orthopedic injuries, sports injuries, cumulative trauma disorders, occupational injuries, concussions and vestibular disorders.Farner is also full body certified in both Active Release Techniques, Trigger Point Dry Needling and is a Certified Vestibular Rehabilitation Specialist.

"I'm very excited for this opportunity to lead the PT programs at the Brighton clinic," said Farner, Clinic Partner & Director. "By expanding care to the Brighton community, we close a significant gap between those needing quality pain management support and the resources available to them. If you are in need of physical therapy care, no doctor or healthcare practitioner referral is needed, so come visit our Brighton clinic today and you'll see why our patients love coming to us."

Pro Active accepts most insurance plans and will work with patients to help them better understand benefits and what services will be covered by insurance. To learn more about Pro Active, please visit proactivecolorado.com.

For more information on PRN locations or partnership opportunities, visit PRNpt.com. You can also follow us @PRNPhysicalTherapy onFacebook, @PRN_therapy onTwitteror onLinkedIn.

COVID-19 Safety Statement

With safety as a top priority,Pro Active is actively taking the necessarysteps to ensure patient care is completed with strict infection control measures.Pro Active will continue to act with an abundance of caution in alignment with recommendations fromthe U.S.Centers for Disease Control and Prevention (CDC) the Occupational Safety and Health Administration (OSHA) and local health officials.

About Physical Rehabilitation Network

Founded in 1991, Physical Rehabilitation Network, LLC., (PRN) is a privately held physical therapy care provider and comprehensive practice management organization providingnon-clinical, administrative support services tophysical therapists across 11 states in the western and central portions of the U.S. Headquarteredin Carlsbad, Calif., PRN currently supports over 130 locations and 20 brands including its PRN-affiliated clinic network in Southern California. PRN is known for its leading, value-driven practice management services and innovative, outcomes-drivenphysical therapy care.

Media Contact

Brian Rog

media@prnpt.com

Related Images

pro-active-physical-therapy.jpg Pro Active Physical Therapy Pro Active Physical Therapy delivers the highest quality of rehabilitative care provided by licensed Physical Therapists. Our Therapists have completed hundreds of post-graduate education hours and have received several additional certifications beyond formal physical therapy education.

Related Links

Become a PRN Partner

Pro Active PT Official Website

View original content to download multimedia:http://www.prnewswire.com/news-releases/pro-active-physical-therapy--sports-medicine-opens-a-new-clinic-in-brighton-301170354.html

SOURCE Physical Rehabilitation Network

Excerpt from:
Pro Active Physical Therapy & Sports Medicine Opens a New Clinic in Brighton - Insurance News Net

Maryland University of Integrative Health Offering Complimentary Telehealth Acupuncture to Maryland Residents Wall Street Call – Reported Times

iCrowdNewswire Nov 11, 202010:00 AM ET

Laurel, Md. Maryland University of Integrative Health (MUIH) is now offering complimentary virtual acupuncture telehealth visits to Maryland residents. There is always a need for individuals to focus on their health and wellness, and the need is even greater during this pandemic. MUIH is stepping up to address this need by offering free virtual acupuncture telehealth visits.

A typical acupuncture in-person visit includes treatment with needles but there is much more that occurs and these other aspects can be provided via telehealth. Part of the underlying wisdom of traditional Chinese medicine is its focus on self-care and health promotion. MUIH acupuncturists are educated in movement therapy such as qi gong and Tai chi. They can impart dietary advice, lead people through breathing exercises and body awareness techniques, and some also suggest herbs. Additionally, they can guide clients through self-applied acupressure treatments. The free telehealth services will be provided by MUIH students under the supervision of a licensed practitioner.

Patients who pursue ongoing treatment for maintenance and promotion of good health report: staying well longer and recovering from illness more quickly; improved stamina and vitality; improved capacity to positively influence their health; reductions in long-term health-care costs and less frequent visits to physicians; and deepened and more harmonious relationships with others.

We are committed to providing the community with uninterrupted care, holistic health tools, and relationship-centered attention to our clients, said Michelle McNear, Ph.D., Director of the Natural Care Center at MUIH.

To schedule a free visit or request more information call the Natural Care Center at 410-888-9048 ext. 6614 or send an email message to [emailprotected].

About Maryland University of Integrative Health (MUIH)

Maryland University of Integrative Health (MUIH) is a leading academic institution focused on the study and practice of integrative health and wellness and one of the few universities in the U.S. dedicated solely to such practices. Deeply rooted in a holistic philosophy, its model for integrative health and wellness is grounded in whole-person, relationship-centered, evidence-informed care.

Since 1974, MUIH has been a values-driven community educating practitioners and professionals to become future health and wellness leaders through transformative programs grounded in traditional wisdom and contemporary science.

MUIH has more than 20 progressive graduate degree programs in a wide range of disciplines, offered on-campus and online. In the on-campus Natural Care Center and community outreach settings, MUIH provides compassionate and affordable healthcare from student interns and professional practitioners which delivers more than 20,000 clinical treatments and consultations each year.

For more information visit http://www.muih.edu.

Also Read:

Kionne S. Johnson Communications Manager [emailprotected]

Keywords:MUIH, Telehealth, Acupuncture, Maryland, Health, Wellness

View post:
Maryland University of Integrative Health Offering Complimentary Telehealth Acupuncture to Maryland Residents Wall Street Call - Reported Times

BrainTap Examines The Effects Of Brainwave Entrainment On College Athletes to Improve Overall Well Being – PR Web

Seminole College Students Braintapping

DURHAM, N.C. (PRWEB) November 09, 2020

BrainTap, the leading enhanced meditation company, is launching a new study in collaboration with Seminole State College of Florida to evaluate the emotional and physical effects of Brainwave Entrainment on the 2019 NJCAA champion womens golf team. This study will allow further insight into the overall influence of BrainTap technology on college athletes, as well as how it affects the everyday user.

Brainwave entrainment was first discovered in 1934 and refers to the use of rhythmic auditory and visual stimuli to induce a desired state of mind. The digital revolution has vastly expanded entrainment possibilities and has created a growing demand for research in this area.

The study is being conducted using the BrainTap headset, a consumer digital wellness device designed to help users find improved clarity, quality sleep, and more energy. BrainTap uses a proprietary audio/visual algorithm to enable more relaxed brainwave states, contributing to health and wellness improvements.

Were really excited to be working with BrainTap on this study, said Dr. Geraldine L. Perez Director, Disability Support Services at Seminole State College. We want to give our students resources to help them balance their busy lives and BrainTaps entrainment technology has the potential to make a real difference.

The study continues a trend of research conducted by BrainTap, which earlier this year presented two studies at the prestigious International Congress on Integrative Medicine and Health. The first was conducted at the Laboratory of Experimental Neuroscience - University of South Santa Catarina and found that audio-visual brain entrainment significantly increased quality of sleep amongst university students; the second showed that a single audio-visual brain entrainment session with the BrainTap Headset could significantly influence heart rate variability, parasympathetic activity, and decrease stress.

What makes BrainTap so effective is the powerful science at the heart of the technology. Were committed to incorporating the latest science and research in improving our products, said lead researcher Dr. Francisco Cidral, ND, PhD. This current study is part of our ongoing effort to provide valid methodology and controlled clinical evidence evaluating the effects of this non-invasive approach to enhancing performance and ultimately changing lives.

ABOUT BRAINTAP:BrainTap is the leader in enhanced meditation. Its products bring improved clarity, quality sleep, and more energy to users around the world. More than 3 million sessions have been played and BrainTap is trusted by over 2300 healthcare professionals. Based on the extensive work of Dr. Patrick Porter, PhD, BrainTap recently released a consumer-grade mobile application - BrainTap Pro - to advance its mission to better a billion brains. BrainTap offers over 1000 original audio sessions in 12 languages within its mobile app. The company also offers an optional, patent-pending headset. BrainTap has been featured in Bloomberg Businessweek, Entrepreneur, Fast Company, Fortune, Health, Inc., People, The Wall Street Journal and on ABC, CBS, NBC, and FOX.

For more information visit: http://www.braintap.com

ABOUT SEMINOLE STATE COLLEGE OF FLORIDA: Seminole State College of Florida, established in 1965, serves nearly 30,000 students across six sites in Central Florida. A comprehensive college, Seminole State has awarded more than 100,000 credentials, from bachelor's degrees to high school diplomas, and offers more than 200 degrees, certificates and programs designed for success. For more about the college, visit: seminolestate.edu, follow on Facebook, and Twitter.

Share article on social media or email:

Read more:
BrainTap Examines The Effects Of Brainwave Entrainment On College Athletes to Improve Overall Well Being - PR Web

23 New Mom Gifts Thatll Make The First Year Less Stressful – Allure

Life as a new mom is hard as it is. Factor in a pandemic, spending months indoors, and having to wear a face mask to do basic things like head to doctor appointments and grocery store run, and it's completely understandable if your new mom friends are ready to pull their hair out. Now is the perfect time to show them just how solid of a support system they have in you with a gift to help ease their day-to-day challenges.

While they may not be dealing with the woes or homeschooling just yet, learning the ins-and-outs of caring for a new baby, all while trying to maintain some semblance of a self-care routine is a hell of a lot of work. Show them some love with these helpful items that'll make life as a new mom a lot more comfortable.

Between the pregnancy acne and chafing from nursing, dealing with pre- and post-baby skin can feel like it's on a wild roller coaster ride. Help your mom friends and family keep their skin soft, soothed, and chap-free with the help of Mutha Body Butter, a whipped blend of moisturizing shea, cocoa, and mango butters. Or for those areas that need a bit more love, Lano's Golden Dry Skin Salve is a multi-purpose balm that heals cracked, lips, hands, and heels.

And with its mousse-like texture and cocoa butter and jojoba oil-laced formula, the Allure Best of Beauty-winning Ever Lavish Ultra Rich Body Butter is an even more luxurious moisturizing gift to give.

The Conscious Coconut Home Bath Bundle comes with a jar of organic coconut oil and a dry brushing tool to exfoliate rough skin. New moms in your life who are already familiar with the fan-favorite Bio-Oil original formula will likely be into the brand's newest launch, the Bio-Oil Dry Skin Gel. Thirty years after the launch of its first product, Bio-Oil introduced a gel-to-oil formula with glycerin and urea to help moisturize intensely dry skin. It's a perfect addition to any unpredictable, post-pregnancy skin-care routine.

The Burt's Bees Tips and Toes Kit Gift Set was made especially for dry extremities. The six-piece set has a hand cream, foot cream, multi-purpose salve, cuticle cream, lip balm, and travel-size hand cream all with skin-nourishers like sweet almond oil and vitamin E.

Continue reading here:
23 New Mom Gifts Thatll Make The First Year Less Stressful - Allure

Pinpointing the Pain with Trigger Point Therapy – Mpls.St.Paul Magazine – Mpls.St.Paul Magazine

If you suffer from chronic pain, there might come a time when you think that youve tried everything and have to resign to living in constant discomfort. But practitioners of trigger point therapy say they can put their finger right on the source of your painand help ease it.

Pain doesnt have to be your normal, says Spring Saldana, massage therapy program chair at Northwestern Health Sciences University in Bloomington.

In fact, she says trigger point therapy can help relieve that crick in your neck, frequent headaches, back pain, plantar fasciitis, and other chronic pain issues.

Saldana, BCTMB and CNMT, is board certified in therapeutic massage and bodywork, and certified in neuromuscular therapy. She describes a trigger point as a hyperirritable nodule or knot that can be found in connective tissue and muscle tissue in hundreds of places on the human body.

Those knots and nodules can restrict blood flow and keep nutrients and oxygen from getting to the area, causing waste buildup that, in turn, creates inflammation and pain. In trigger point therapy, practitioners find your trigger points and press on them to help the knot or nodule release, which can relieve your pain.

Whats interesting about trigger points is their ability to refer pain and symptoms to other parts of the body.

Theres a little space between your neck and shoulder where vital things like nerves and blood vessels go through, called the brachial plexus, which supplies the nerves in the arm, she says. Sometimes the muscles of the neck and chest can pinch that bundle of nerves, and cause numbness or tingling and even pins and needles in your arm and hand, but its coming from the compression of the brachial plexus, higher up in your neck and shoulder."

Some trigger points in the neck, head, and face can cause vertigo and dizziness, migraines, numbness or tingling in the face, toothaches, and TMJD symptoms. Trigger points in other parts of the body can cause back pain, irritable bowel syndrome, plantar fasciitis, carpal tunnel, and more.

Easing Up to the Trigger Point

In your initial appointment at Northwestern Health Sciences Bloomington Clinic, a certified neuromuscular massage therapist will discuss your pain and assess your posture and gait to see if you move freely or are putting weight to one side. That will help narrow down which trigger points might be causing your discomfort.

If somebody has a high right shoulder, Saldana says, that tells me there are, between the shoulder and the ear on that side, probably some kind of trigger points, because posture is off.

Thats going to tell me which muscles are involved, which ones will be more tight, she says. I am going to look for trigger points in that area.

When a new patient describes knots in certain areas, Saldana will palpate that area to assess the soft tissue quality and locate the trigger point(s).

After the intake and assessment, Saldana says treatment begins with a massage that works up to trigger point therapy. In other words, attacking the trigger point immediately and causing unduepain is not the goal.

I would start out just working through the layers, she says. I would start with myofascial release, and then I would move into more Swedish strokes, working to a deeper level with those types of strokes. Once the tissue is ready, I would go into trigger point therapy.

Will it Hurt?

I dont believe in no pain, no gain, Saldana says. There are some trigger point therapists that do believe that, but the body will guard against me if I try to go too hard too fast. It is important to work smarter, not harder. I want to get the most out of the treatment session by working through the tissue layers.

Instead, Saldana doesnt want to go past the clients edge. Trigger point therapy treatment does not have to be painful. It may be uncomfortable, but it should stay at a good hurt intensity.

I am going to get on that knot and apply static pressure, she says. If we stay at the clients edge, which can be uncomfortable, but not cause pain, I can avoid causing guarding from the clients body.

Saldana will do a series of three presses on a trigger point with the intention of getting deeper and deeper into the tissue to alleviate pain and symptoms.

The goal is for long-term pain and symptom relief. Some pain can be relieved in a single session, while other chronic pain may take a series of treatments that tapers off as the pain diminishes. She says trigger point therapy helps reprogram the bodys muscle memory to keep pain away.

It is definitely an effective and preventative type of bodywork that, when used correctly and done by someone who is certified,can save you money, because of surgeries and medical bills, she says. It can reduce pain and increase quality of life for the long term.

Located in Bloomington,Northwestern Health Sciences Universityis a pioneer in integrative natural health care education, offering degree programs in chiropractic, acupuncture, Chinese medicine, massage therapy, medical assisting, medical laboratory programs, post-bac/pre-health, radiation therapy, and B.S. completion. ItsBloomington clinicis open to the public andprovides chiropractic treatment,acupuncture, Chinese medicine, massage therapy, naturopathic medicine, cupping, and physical therapy.

See more content fromNorthwestern Health Sciences University.

Sign up for our Be Well newsletterto get the latest health and wellness coverage.

View post:
Pinpointing the Pain with Trigger Point Therapy - Mpls.St.Paul Magazine - Mpls.St.Paul Magazine

AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting – AJMC.com Managed Markets Network

Study Design: We used Plan-Do-Study-Act cycles with chart review for pre- and postintervention measurementcollection.

Methods: We included patients hospitalized at The Brooklyn Hospital Center on inpatient general medical wards from January 1, 2017, through July 31, 2018. The intervention consisted of a standard process of reviewing patients on telemetry based on AHA guidelines, educating teams on the guidelines, and changes to telemetry order sets. The primary outcome measured was the total number of days that patients remained on telemetry. Secondary measures included the daily number of telemetry downgrades and total number of patients on telemetry. Diagnosis-related group and case mix index were also noted.

Results: Patient average days on telemetry changed from 7.20 days preintervention to 3.51 days post intervention (P<.0001). The number of patients on telemetry with a diagnosis meeting AHA guidelines for telemetry increased.

Conclusions: The stated intervention resulted in more effective use of telemetry, evidenced by fewer patient days on telemetry and increased numbers of patients on telemetry meeting AHA guidelines for telemetry.

Am J Manag Care. 2020;26(11):In Press

_____

Takeaway Points

This study addresses the use of telemetry in the inpatient setting and examines the effect of tracking and adjusting telemetry time on length of stay in the hospital.

_____

Telemetry usage on inpatient general medical wards has been identified as an area where resources are utilized inappropriately, which leads to higher costs and a negative impact on patient experience. One study showed that clinical care changed in only 7% of patients on telemetry as a result of their telemetry usage.1 Telemetry overutilization costs approximately $54 per patient per day, and each hospitalization day can cost $1400 per day.2-5 Using telemetry when it is not needed can increase costs associated with telemetry administration, diminish hospital throughput, and cause delays and increased patient length of stay (LOS). Additionally, inappropriate use of telemetry may result in a negative patient experience due to alarm sounds, artifact data leading to excessive procedures, and provider alarm fatigue.6

In 2013, the Society of Hospital Medicine added recommendations to the Choosing Wisely campaign, recommending that all nonintensive care telemetry decisions should be protocol-driven to reduce waste.7 Additionally, in 2017, the American Heart Association (AHA) revised its 2004 telemetry guidelines.8,9 Since the AHA guidelines were first published, individual studies demonstrated that the guidelines improved appropriate telemetry utilization when applied in the context of institution-specific clinical guidelines. Despite telemetry guidelines, overutilization remains a problem. The reasons are multifactorial: Hospitals may not have guidelines in place to regulate the use of telemetry, providers may be unaware that a patient under their care is on telemetry, provider practice patterns on telemetry use deviate from guideline recommendations, and there is insufficient continuing education about guidelines for appropriate use of telemetry.1,10,11 One study found that, among interviewed clinical providers, accurate assessments for telemetry indications were made 80% of the time whereas only 26% of participants were aware that their patient was on telemetry; 42% did not give a correct indication for telemetry use.12 Another study showed that order sets guiding telemetry use in accordance with AHA guidelines decreased weekly telemetry orders by more than half and avoided an estimated $4.8 million of waste annually.13

An evidence-based implementation guide by Yeow et al14 considered 8 interventions addressing telemetry use for hospitalized patients.Four of the 8 interventions implemented changes in the electronic health record (EHR) to improve telemetry utilization. Two of the 8 interventions incorporated an educational component to ensure adherence to appropriate telemetry use. Three of the 8 interventions incorporated an educational component to influence a teams decision on telemetry use. Of the interventions observed, 7 resulted in a decreased duration of telemetry days, whereas the intervention by Boggan et al15 did not affect patient days on telemetry. Despite various quality improvement activity initiatives relating to telemetry, telemetry overutilization remains problematic, and there is a lack of best practices on how to implement programs that regulate telemetry use within hospitals.13,16

METHODS

The study period was 18 months, from January 1, 2017, through July 31, 2018. All patients hospitalized at The Brooklyn Hospital Center (TBHC), a 464-bed urban tertiary care hospital in Brooklyn, New York, on the inpatient general medical wards and on telemetry during this period were included in the study. Patients who were 18years or older were included. Exclusion criteria included being in the medical intensive care unit and being 17 years or younger. The study design involved chart review for pre- and postintervention measurement collection. Preintervention data included EHR data collected prior to August 1, 2017. The intervention began on August 1, 2017, and changes were sustained for the duration of the study. Postintervention data included patients who were on telemetry in the period stated previously. Patient days on telemetry each month were analyzed. The pre- and postintervention groups patient telemetry days were compared, with case mix index (CMI) factored into our multivariable adjusted analysis. SAS 9.4 (SAS Institute) was used to analysis the data. Additionally, the number of patients downgraded off telemetry during our multidisciplinary rounds (MDRs) each day was monitored. Continuous variables that were normally distributed were expressed as means and SDs. Categorical variables were presented as frequencies. Multivariate linear regression was performed to determine whether the intervention was associated with changes in telemetry utilization and hospital LOS after adjusting for age, gender, race, and the Medicare Severity Diagnosis-Related Group (MS-DRG) (federal and New York State weight). A P value.05 (2-tailed) was considered statistically significant.

To calculate the average cost savings per month, we first calculated the difference of mean telemetry LOS between the preintervention and postintervention periods () by subtracting the average telemetry LOS for each month of the postintervention period from the average telemetry LOS for the preintervention period that extended from January 2017 to July 2017. We then calculated the total patient days for each month of the postintervention period by multiplyingby number of patients for each. Finally, we used $34, as reported,17 as an average daily cost savings for telemetry use and multiplied $34 by the number of patient days per month to ultimately obtain total cost savings for 11 months (from August 1, 2017, to June 31, 2018) and average savings per month.

Telemetry usage data were collected from the EHR (Allscripts 3.0) on patients utilizing telemetry during the study period. Approval was received from The Brooklyn Hospital Center Institutional Review Board on April 26, 2018, that encompassed data collection inclusive of the pre- and postintervention periods.

Our hospitals Patient Flow Committee oversees hospital throughput and meets monthly. One charge for this committee is patient overcrowding in the emergency department, which was linked to inpatient cardiac telemetry utilization. The committee includes various stakeholders from multiple departments, including resident physicians, nurses, and nursing managers from the internal medicine and emergency medicine departments. We developed 2focused interventions with regard to improved telemetry utilization to address these behaviors and knowledge barriers.

We chose to use Plan-Do-Study-Act (PDSA) cycles in this study to allow for rapid assessment of an intervention. The study intervention was designed and piloted for a 2-week period before the first PDSA cycle was implemented (Figure). Two hospital medicine teams were involved in the pilot phase. The chief quality resident (CQR) and a nurse sat in MDRs daily and discussed all telemetry patients with the 2 hospital medicine teams involved. Specifically, they were asked, Does your patient need telemetry and meet criteria for telemetry? Based on the reply from the resident and attending physicians, a computerized order to discontinue telemetry could be immediately entered, if indicated, using a computer on wheels. Nurses and the CQR were also given pocket cards designed to highlight AHA criteria for telemetry as a decision aid tool (eAppendix Figure [eAppendix available at ajmc.com]).

In PDSA cycle 1, the interventions were planned for broader implementation at TBHC with the aim of further reducing patient telemetry days hospital-wide. For PDSA cycle 1, the CQR and nursing staff attended MDRs for all 6 of the hospitalist teams. If telemetry was not needed, orders to discontinue telemetry were entered immediately. The CQR and nursing staff distributed the decision aid pocket card to the attendings and resident physicians of all teams. PDSA cycle 1 lasted for 4 weeks.

In the next cycle, PDSA cycle 2, the intervention described in PDSA cycle 1 was continued with addition of a 48-hour automatic discontinuation order for all telemetry orders.

RESULTS

Of the 3245 patients who were placed on telemetry during the study period and who met study inclusion criteria, 1340 patients were in the preintervention group and 1905 patients were in the postintervention group (Table 1). We found that patient average telemetry days in the preintervention group were 7.20 days and in the postintervention group were 3.51 days (Table 1). The intervention resulted in a 51.25% mean reduction of patient telemetry days (P<.0001) after using multivariate analysis and adjusting for age, gender, race, and MS-DRG. We noted that the preintervention mean hospital LOS was 7.48days compared with 5.68 days post intervention (P<.001).

The most common cardiac diagnoses for which telemetry was ordered in the preintervention and postintervention phases were acute coronary syndrome (ACS) (18.21% preintervention and 21.31% post intervention) and heart failure (HF) (10.90% preintervention and 9.29% post intervention) (Table 1). The mean MS-DRG (federal weight) during the study period was 1.47 in the preintervention period and 1.80 in the postintervention period, but this increase did not achieve statistical significance.

The monthly average of patient average telemetry days declined to 2.98 days at the end of the postintervention period in June 2018 (Table 2) from 8.66 days at the beginning of the preintervention period in January 2017 (Table 3), thus constituting a total decline of 5.68 days (65.69%) in monthly patient average telemetry days from beginning to end of the study. Additionally, there was an overall increase in the total number of patients on telemetry from 153 patients in January 2017 (Table 3) to 217 patients in June 2018 (Table 4), and a greater number of these were using telemetry appropriately, according to AHA guidelines.

For all patients in the postintervention group (Table 4), patient days on telemetry decreased compared with the preintervention group regardless of the diagnosis or telemetry unit (eAppendix Table1). For instance, mean telemetry LOS for gastrointestinal bleed was 9.56 days vs 4.80 days; for arrythmia was 8.68 days vs 3.80 days; for asthma/chronic obstructive pulmonary disease exacerbation was 8.28 days vs 4.45 days; and for altered mental status was 8.24 days vs 3.75 days. Values for chest pain, ACS, electrolyte abnormality, congestive HF exacerbation, cerebrovascular accident, syncope, seizures, and sepsis are shown in eAppendix Table 1. We also noted a decrease in the number of patients placed on telemetry for gastrointestinal bleed, syncope, and sepsis. Although patient telemetry days significantly decreased, nontelemetry patients hospital LOS increased slightly during the intervention period. The CMI also increased from 1.4 in the preintervention period to 1.64 in the postintervention period.

The monthly average decline of patient telemetry days ranged from 1.21 days to 4.22 days during the postintervention period (eAppendix Table 2). Additionally, the total intervention cost savings was $244,199.90 in 11 months, for an average savings of $22,199.99 per month (eAppendix Table 2).

DISCUSSION

Despite efforts to raise awareness on a national level, inappropriate telemetry use is still high and remains problematic for multiple reasons.18,19 Up to 43% of patients on telemetry lack appropriate indications for telemetry.20 Our initial assessment of telemetry utilization in the hospital showed that telemetry was not frequently reassessed once it was started. Additionally, other studies suggest that a lack of provider knowledge about whether their patients were on telemetry was a large contributor to excessive telemetry days.12,21 The telemetry management approach developed and implemented in this study may be a feasible framework for ensuring appropriate use of telemetry in accordance with AHA guidelines and local needs. The novel approaches of the study intervention included interdisciplinary team collaboration for resource management and daily tracking of telemetry use during MDRs.

The goal of this effort was to reduce hospital-wide patient telemetry days by creating more effective standardization for utilization of telemetry. By breaking down our interventions into PDSA cycles and measuring patient telemetry days and secondary outcomes, we were able to achieve our stated quality improvement goals. We observed from our pilot study that the main limiting factor for prolonged number of patient telemetry days was that physicians did not have reminder mechanisms in place to help them reevaluate the need for telemetry. In other words, if telemetry was not reassessed during a hospital stay, it could be left on for days longer than indicated. Our intervention created structure integrated into the physician workflow that facilitates continuous reassessment of telemetry, thereby enabling physicians and the care team to use telemetry resources more judiciously. This personalized, team-based approach resulted in an effective reduction of patient telemetry days at our institution. Additional support integrated into the workflow through changes to the EHR resulted in further improvements, which was also noted in other studies.

In fact, review of the literature shows that changes to the EHR are among the most common and effective ways of reducing telemetry LOS. The study by Dressler et al implemented revised telemetry order sets and reported a 43% reduction in mean weekly telemetry orders placed and a 47% reduction in the mean duration of telemetry hours.13 One study required physicians to select a clinical indication for telemetry with a duration for monitoring, which was associated with a multifaceted intervention that included guideline education, removal of telemetry orders from admission order sets, daily discussion of telemetry by hospitalists, monthly feedback, and financial incentives for meeting targets.22 It showed a 69% reduction in telemetry use within the hospitalist medicine group.22 On the other hand, the study by Boggan et al15 did not affect patient days on telemetry. A study by Stoltzfus et al23 used a bed huddle first, followed by a subsequent intervention that forced physicians to indicate a reason for telemetry on admission orders in the EHR. It showed an initial drop in telemetry use with a return to preintervention baseline, as there was no major reduction and even some instances of increased telemetry use with the huddle intervention in certain studied patient units, but it had a 17.8% relative decrease in hospital-wide telemetry use using the physician-based order-related intervention.23

Increasingly, hospitals are using interprofessional health care teams consisting of employees with different types of training (eg, attending physician, resident, nurse) to tackle specific problems. Team-based care is rooted in the premise that optimal health care delivery is determined by a complex set of relationships among different types of caregivers, and these relationships are associated with higher performance.24,25 Prior to our intervention, decisions regarding the use of telemetry were made by a single physician functioning as the sole decision maker. Upon implementation of our process utilizing interdisciplinary teams, improper use of telemetry decreased. Use of telemetry for diagnoses where telemetry was not indicated also decreased, and mean patient days on telemetry decreased. We noted that the use of telemetry for inappropriate clinical indications, such altered mental status, also decreased after our intervention was in place.

The overall increase in the total number of patients on telemetry from 153 patients in January 2017 to 217 patients in June 2018 suggests that there was improved understanding of appropriate clinical indications to start telemetry or continue it appropriately. The decrease in the daily number of telemetry downgrades from the beginning to the end of the study period can be attributed to the seasonal shifts in the hospitals total patient census. The CMI was higher in the postintervention period because those months correspond to a high patient census time in the calendar year when overcrowding of the emergency department and high hospital bed occupancy rates are seen. Thus, it appeared that our telemetry interventions effectively reduced patient telemetry days, regardless of the clinical complexity of the patients and high patient census. These findings support the development and implementation of an interprofessional health care team in quality improvement efforts toward appropriate use of telemetry. By leveraging a team to create accountability, we saw better utilization of resources. Nonetheless, further investigation can be done to assess the sustainability of such an intervention and identify additional novel interventions for continued improvement.

It has been reported that a waste reduction at a medium-sized community hospital with 175 telemetry-capable beds could translate to annual cost savings of $213,986.17 Indeed, we found an intervention cost savings of roughly $244,000 for 11 months. Therefore, every possible measure should be pursued to minimize the inappropriate use of telemetry, including care provider training and education, as well as EHR-based protocolization of telemetry monitoring.17

The possibility of other interventions, such as financial incentives that may be awarded to health group providers or department divisions for physician-driven cost-saving improvement projects, may interfere with the accuracy of studies. For example, the intervention by Edholm et al utilized a financial incentive for the hospitalist group to encourage judicious use of telemetry.22 Studies would be needed to characterize whether financial incentives or other approaches are appropriate and effective in improving appropriate telemetry usage. No financial incentive was applied in our study.

Limitations

The limitations of our study included the retrospective nature of the study, which relies on the quality of documentation by the health provider teams, as well as on continuity of the educational intervention for incoming residents and staff despite staff turnover. With resident rotation switches, there is a continuing need for education about the initiative. Another limitation was nontelemetry bed capacity; even if a clinical team appropriately discontinued telemetry, it is possible that a patient remained in a telemetry bed simply because a nontelemetry bed was not available. Data about patient telemetry days were derived from data available in the EHR, which could have resulted in a falsely higher number of patient telemetry days. However, this would suggest that the patient days on telemetry reported may actually be an underestimation of the actual effect of the intervention. This was a single-center study, and this may limit the generalizability of the intervention, as other hospitals may lack similar resources to implement our intervention protocols and achieve similarly successful results. Additionally, we did not use postintervention surveys to confirm long-term understanding by medical house staff residents, attendings, and other personnel. This would also be important to maintain consistently good clinical practice with respect to appropriate telemetry use. Despite these limitations, the interventions implemented in this qualitative improvement study appeared to be feasible and resulted in a positive impact that could be replicated at individual institutions seeking to improve appropriate telemetry utilization.

CONCLUSIONS

Our intervention showed that we can reduce hospital inpatient telemetry usage by half with appropriate reminder mechanisms involving not only physicians but all other professional caregivers. An interprofessional care team resulted in increased adherence to AHA guidelines for telemetry usage in addition to reduced costs, shared accountability, and improved quality of health care. The effectiveness and sustainability of such team-based approaches to enhance health care quality require further studies.

Author Affiliations: The Brooklyn Hospital Center (SSP, IBB, SP, AG, ANL, JJG), Brooklyn, NY; Icahn School of Medicine at Mount Sinai (SSP, JJG), New York, NY; Harvard Medical School (IBB), Boston, MA; Maastricht University (TIL), Maastricht, Netherlands.

Source of Funding: None.

Author Disclosures: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.

Authorship Information: Concept and design (SSP, IBB, SP, ANL, JJG); acquisition of data (SSP, IBB, SP, ANL, JJG); analysis and interpretation of data (SSP, IBB, SP, AG, ANL, JJG); drafting of the manuscript (SSP, IBB, SP, TIL, AG, ANL, JJG); critical revision of the manuscript for important intellectual content (SSP, IBB, SP, TIL, AG, ANL, JJG); statistical analysis (SSP, IBB, AG, JJG); provision of patients or study materials (SSP, JJG); obtaining funding (SSP, JJG); administrative, technical, or logistic support (SSP, IBB, TIL, JJG); and supervision (SSP, JJG).

Address Correspondence to: Sima S. Pendharkar, MD, MPH, The Brooklyn Hospital Center, 317 Hart St, Unit 2, Brooklyn, NY 11206. Email: spendharkar@tbh.org.

REFERENCES

1. Estrada CA, Rosman HS, Prasad NK, et al. Role of telemetry monitoring in the non-intensive care unit. Am J Cardiol. 1995;76(12):960-965. doi:10.1016/s0002-9149(99)80270-7

2. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513-1516. doi:10.1001/jama.2012.362

3. Heget JR, Bagian JP, Lee CZ, Gosbee JW. John M. Eisenberg Patient Safety Awards. system innovation: Veterans Health Administration National Center for Patient Safety. Jt Comm J Qual Improv. 2002;28(12):660-665. doi:10.1016/s1070-3241(02)28071-2

4. Institute of Medicine Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press; 2001.

5. Kizer KW. Patient safety: a call to action: a consensus statement from the National Quality Forum. MedGenMed. 2001;3(2):10.

6. Cvach M. Monitor alarm fatigue: an integrative review. Biomed Instrum Technol. 2012;46(4):268-277. doi:10.2345/0899-8205-46.4.268

7. Bulger J, Nickel W, Messler J, et al. Choosing wisely in adult hospital medicine: five opportunities for improved healthcare value. J Hosp Med. 2013;8(9):486-492. doi:10.1002/jhm.2063

8. Drew BJ, Califf RM, Funk M, et al; American Heart Association. Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation. 2004;110(17):2721-2746. doi:10.1161/01.CIR.0000145144.56673.59

9. Sandau KE, Funk M, Auerbach A, et al; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young. Update to practice standards for electrocardiographic monitoring in hospital settings: a scientific statement from the American Heart Association. Circulation. 2017;136(19):e273-e344. doi:10.1161/CIR.0000000000000527

10. Saleem MA, McClung JA, Aronow WS, Kannam H. Inpatient telemetry does not need to be used in the management of older patients hospitalized with chest pain at low risk for in-hospital coronary events and mortality. J Gerontol A Biol Sci Med Sci. 2005;60(5):605-606. doi:10.1093/gerona/60.5.605

11. White HL, Glazier RH. Do hospitalist physicians improve the quality of inpatient care delivery? a systematic review of process, efficiency and outcome measures. BMC Med. 2011;9:58. doi:10.1186/1741-7015-9-58

12. Sharma P, Tesson A, Wachter A, Thomas S, Bae JG. Physician awareness of patient cardiac telemetry monitoring. J Hosp Adm. 2016;5(3):76-80. doi:10.5430/jha.v5n3p76

13. Dressler R, Dryer MM, Coletti C, Mahoney D, Doorey AJ. Altering overuse of cardiac telemetry in non-intensive care unit settings by hardwiring the use of American Heart Association guidelines. JAMA Intern Med. 2014;174(11):1852-1854. doi:10.1001/jamainternmed.2014.4491

14. Yeow RY, Strohbehn GW, Kagan CM, et al. Eliminating inappropriate telemetry monitoring: an evidence-based implementation guide. JAMA Intern Med. 2018;178(7):971-978. doi:10.1001/jamainternmed.2018.2409

15. Boggan JC, Navar-Boggan AM, Patel V, Schulteis RD, Simel DL. Reductions in telemetry order duration do not reduce telemetry utilization. J Hosp Med. 2014;9(12):795-796. doi:10.1002/jhm.2264

16. Najafi N. A call for evidence-based telemetry monitoring: the beep goes on. JAMA Intern Med. 2014;174(11):1855-1856. doi:10.1001/jamainternmed.2014.3502

17. Chong-Yik R, Bennett AL, Milani RV, Morin DP. Cost-saving opportunities with appropriate utilization of cardiac telemetry. Am J Cardiol. 2018;122(9):1570-1573. doi:10.1016/j.amjcard.2018.07.016

18. Kansara P, Jackson K, Dressler R, et al. Potential of missing life-threatening arrhythmias after limiting the use of cardiac telemetry. JAMA Intern Med. 2015;175(8):1416-1418. doi:10.1001/jamainternmed.2015.2387

19. Sivaram CA, Summers JH, Ahmed N. Telemetry outside critical care units: patterns of utilization and influence on management decisions. Clin Cardiol. 1998;21(7):503-505. doi:10.1002/clc.4960210709

20. Chen EH. Appropriate use of telemetry monitoring in hospitalized patients. Curr Emerg Hosp Med Rep. 2014;2:52-56. doi:10.1007/s40138-013-0030-6

21. Henriques-Forsythe MN, Ivonye CC, Jamched U, Kamuguisha LKK, Olejeme KA, Onwuanyi AE. Is telemetry overused? is it as helpful as thought? Cleve Clin J Med. 2009;76(6):368-372. doi:10.3949/ccjm.76a.07260

22. Edholm K, Kukhareva P, Ciarkowski C, et al. Decrease in inpatient telemetry utilization through a system-wide electronic health record change and a multifaceted hospitalist intervention. J Hosp Med. 2018;13(8):531-536. doi:10.12788/jhm.2933

23. Stoltzfus KB, Bhakta M, Shankweiler C, Mount RR, Gibson C. Appropriate utilisation of cardiac telemetry monitoring: a quality improvement project. BMJ Open Qual. 2019;8(2):e000560. doi:10.1136/bmjoq-2018-000560

24. Weiss D, Tilin FJ, Morgan MJ. The Interprofessional Health Care Team: Leadership and Development. 1st ed. Jones & Bartlett Publishers; 2014.

25. Donovan AL, Aldrich JM, Gross AK, et al; University of California, San Francisco Critical Care Innovations Group. Interprofessional care and teamwork in the ICU. Crit Care Med. 2018;46(6):980-990. doi:10.1097/CCM.0000000000003067

Originally posted here:
AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting - AJMC.com Managed Markets Network

Pre-Thanksgiving COVID-19 testing for employees and medical school students – Rowan Today

Rowan University has partnered with LabCorp Employer Services to provide free at-home, self-collected COVID-19 testing for employees and medical school students. Nasal swab tests from Pixel by LabCorp can be ordered online here. The visitor access code to create your account is rowan. For more information about the testing process, contact LabCorps customer support at 1-844-251-6524.

How testing works

The kit, which will be delivered to homes and returned to the lab via FedEx, includes all of the supplies you will need, including detailed instructions to complete your self-collection. Upon completing your test and securing it in the postage-paid, pre-addressed FedEx return package, you will deliver it to a FedEx drop box. All instructions will be in your package.

Timing

According to LabCorp, if you order the test by 3 p.m., it will be sent overnight and delivered to your home by FedEx the next day. If you order after 3 p.m., it will be shipped the following morning.

Completed nasal swab tests must be delivered to a FedEx drop box the same day you collect your sample. You will be able to track your sample on the LabCorp web site.

Results

Once received by the lab, results will be available on the secure, online HIPAA-compliant portal where you requested your kit. You will receive an email when your kit has been received and results are ready to view. Results will be available in two to four days. If your test comes back positive for COVID-19, a health care professional will contact you to help you with next steps. Rowan also will be notified about a positive test result.

About testing

Please understand that a negative test does not tell the whole picture. The incubation period for COVID-19 is 2-14 days, meaning there is a window where someone could be infected and still test negative. A test is simply a snapshot in time.

Stay vigilant

As always, to reduce your risk of contracting COVID-19, public health officials recommend reducing the number of potential exposures you may encounter, wearing a mask, focusing on physical distancing and remaining vigilant.

Go here to see the original:
Pre-Thanksgiving COVID-19 testing for employees and medical school students - Rowan Today

How COVID-19 threatens the careers of women in medicine – AAMC

Before she heads out to teach at the University of Cincinnati College of Medicine, Heather Christensen, PhD, preps for the at-home school day of her three children. After work, she makes dinner and does bedtime with the boys all under age 7 followed by work tasks until around 1 a.m.

But thats a lot better than early in the pandemic, when Christensen was educating her kids solo her husbands job cant be done from home making her math teacher, grammar expert, head chef, and school principal. Meanwhile, she was also figuring out how to redesign her medical school courses, which COVID-19 had driven online.

I had what felt almost like PTSD, with extreme fatigue and emotional exhaustion, she says. I couldnt keep doing it.

Now that Christensen has found other people to teach her children, the assistant professor is hoping to return to the research she set aside months ago research that is so crucial to her professional advancement.

Ive been incredibly frustrated, and my sentiments are repeated by almost every woman I speak to, from front-line COVID-19 workers to basic scientists to faculty members, she says. They all echo my frustration, but especially those with young kids.

As the pandemic upends so much in health care and society experts worry that COVID-19 could have dramatic effects on the careers of women in medicine.

Even before the pandemic, women physicians were earning 75 cents for every dollar their male counterparts made. Women also lag in leadership positions, comprising 25% of medical school professors and 18% of deans. And the ranks of women faculty of color have grown just 1 percentage point over the past decade. The research landscape is uneven as well, with women representing 41% of authors, a 2019 article reported.

Now, increased child care responsibilities, diminished opportunities for research and professional development, harassment in online settings, and hiring and promotional issues have women worried that their careers may take a hit for years to come.

Ive been incredibly frustrated, and my sentiments are repeated by almost every woman I speak to, from front-line COVID-19 workers to basic scientists to faculty members.

Heather Christensen, PhDUniversity of Cincinnati College of Medicine professor of medicine

While the full impact wont be known for months, women in medicine are already sounding the alarm. More than 20 women physicians and scientists recently warned that the pandemic could lead to a hemorrhaging of women from academia. In a recent survey, 46% of women medical students said they worry about COVID-19s effect on their careers, versus 36% of men. And a National Academies of Sciences, Engineering, and Medicine (NASEM) webinar noted that many academic jobs lost during the pandemic have been contract, nontenure-track positions jobs often held by women.

Gender inequities brought on by the pandemic must get addressed and soon, experts say. Its not just a social justice issue, argues Amy S. Gottlieb, MD, an associate dean at the University of Massachusetts Medical School-Baystate and the chair-elect of the AAMCs Group on Women in Medicine and Science steering committee. To thrive as a profession, we need to harness the talents of our entire workforce.

Theoretically, the pandemic could offer women physicians increased professional opportunities. Women have been at the forefront of efforts to track down much-needed personal protective equipment, for instance. Mostly, however, experts point to causes for concern.

Child care tops the list. Even before the pandemic, women physician-researchers did more parenting and domestic work than men in similar positions, totaling 8.5 additional hours per week.

Now women are doing even more at home, says Kimberly Templeton, MD, University of Kansas Medical Center professor and past president of the American Medical Womens Association. I worry that they will dramatically reduce their work hours or leave medicine entirely.

But experts also worry that COVID-19 threatens promotion prospects for women with no child care concerns. Thats in part because women get tapped more often to do less-valued tasks, such as writing patient education materials.

Then theres the concern that women have been stymied in publishing, which is so crucial to landing tenure. In fact, the portion of women lead authors in 2020 on COVID-19-related papers was 23% lower than their representation among lead authors in 2019.

It seemed like I kept hitting dead ends, and the men were getting the support. They often have large networks and a lot of resources.

Cynthia Derdeyn, PhDEmory Vaccine Center researcher and professor

Women in academic medicine bear a bigger load of teaching and patient care, notes Reshma Jagsi, MD, DPhil, senior author of the study and a professor at the University of Michigan Medical School. So the transition to virtual care and virtual teaching has created all these demands that are disproportionately falling to women, making it harder to publish.

Cynthia Derdeyn, PhD, had high hopes of contributing to COVID-19 research. After all, she runs a lab at Emory University that researches vaccines and infectious diseases. But, she says, it seemed like I kept hitting dead ends, and the men were getting the support. They often have large networks and a lot of resources.

Experts also fear that women are being hit hard in the online world, where the pandemic has driven so much work.

Women more than men tend to rely on nonverbal communication, and thats hard to do virtually, says Templeton. I worry about women being acknowledged and fully participating in virtual meetings, where its tough to read the room.

Templeton has particular concerns about women of color. She points to a recent webinar for women residency applicants, where many questions came from African American participants wondering how to wear their hair during virtual interviews. Its frustrating that with all that students are facing this year, they also have to worry about unconscious biases related to their appearance, she says.

In addition, women are losing out on vital networking opportunities as conferences move online, notes Eve Higginbotham, MD, vice dean for inclusion and diversity at the Perelman School of Medicine at the University of Pennsylvania. Women really need those sidebar conversations they get at in-person meetings, she says.

But most worrisome to Jagsi is the harassment that can harm women in the online world.

Since the pandemic in particular, weve seen a move toward using Twitter for communication, which leads to responses not just from the professional community, but from the public, she says. Twitter has opened up a number of my female colleagues to requests for dates, vulgar remarks, and really aggressive comments.

If you want your research papers to get noticed and cited, youd better have a Twitter presence, she says. But its the wild, wild west of what people will say to you.

Twitter has opened up a number of my female colleagues to requests for dates, vulgar remarks, and really aggressive comments.

Reshma Jagsi, MDUniversity of Michigan Medical School professor

Experts are working to address the ways the pandemic threatens progress for women in medicine. Here are some of their suggestions.

Step up for parents

Given increased and often unequal responsibilities at home, institutions need to provide women with flexible schedules and robust child care supports, experts argue.

Medical schools and teaching hospitals are trying to help. Indeed, 62% of institutions that provided child care before the pandemic expanded such services after it hit, according to a recent AAMC webinar.

Institutions that dont provide direct child care are assisting in other ways. The University of Florida College of Medicine connects staff and students to nearby nanny agencies, for example, and has negotiated discounts with local child care facilities.

At the University of California, San Francisco, leaders joined with the YMCA to create daylong learning camps in August. So far, some 100 children have attended, mostly from families of health care providers.

Shift promotion processes

To counter potential gender imbalances, institutions must rethink how they reward academic and organizational effort. Gottlieb encourages women to list pandemic-related service work on their CV and performance evaluations, for example.

But perhaps the biggest question is how to handle tenure clocks as COVID-19 hobbles credential-building work. Already, many institutions allow staff to request an extra year before coming up for tenure. Others have taken a much bolder approach: automatically stopping the clock for all candidates (with the option to opt out). Thats the case at Florida State University College of Medicine and Emory University School of Medicine, for example.

Templeton applauds the move. Women often have difficulty requesting something they need, she says. We may think that its just our personal issue, so we dont want to bother anybody. We too often dont feel empowered to speak up.

Actively level the playing field

Last month, leaders in internal medicine published suggestions for protecting women from the fallout of COVID-19. Among their recommendations was to proactively help women advance their careers.

Templeton points to one recent example: Women Orthopedic surgeons created a series of in-depth webinars for women medical students focusing on how best to handle virtual interviews for residency slots.

Also crucial this year is helping junior faculty build their careers through such supports as sponsoring them to present virtually at national conferences, Gottlieb says. At Michigan Medicine, for example, leaders have continued to fund conference registrations and professional society membership despite pandemic-related budgetary pressures.

You cant be what you cant see. So, if women leave medicine or they dont get promoted to leadership positions, Im afraid were at risk of losing future generations of women physicians.

Kimberly Templeton, MDUniversity of Kansas Medical Center professor

When leadership positions do open up, Gottlieb urges decision-makers to focus on equity, such as publicizing opportunities in places where diverse candidates will see them. Lets also make sure interview committees include women and individuals who are underrepresented in medicine, she says.

Higginbotham emphasizes another aspect of equitable hiring and promotion: training those in charge to avoid unconscious biases. At Penn Medicine, she notes, all 5,000 leaders have already received such training.

Pay attention

Finding solutions starts with identifying problems, so leaders advise monitoring how women in medicine are faring. Already, NASEM is exploring COVID-19s impact on women in medicine and science, looking at five domains, including their mental health.

In terms of medical schools and teaching hospitals, options include reaching out to women to assess their concerns. At Rosalind Franklin University of Medicine and Science, for example, the office of diversity arranged monthly calls for women faculty of color to discuss shared COVID-19-related issues and brainstorm possible solutions.

Gottlieb also urges closely monitoring areas where women tend to lag, like compensation. At the Medical College of Wisconsin, despite a hold on salary increases, leaders are continuing to monitor compensation to ensure equity down the road. Such attention is essential, Gottlieb notes, given that women physicians have one of the largest gender pay gaps in the entire U.S. labor market.

As they peer into the future, observers worry about the long-term fallout for women from COVID-19-related obstacles.

You cant be what you cant see, says Templeton. So, if women leave medicine or they dont get promoted to leadership positions, Im afraid were at risk of losing future generations of women physicians.

Meanwhile, Jagsi hopes that this years negative impact could actually lead to a positive turning point.

A year ago, we created a curve depicting womens progress as department chairs and deans. Based on that, we drew a forecast, which shows that if we dont change the curve, it will be 50 years before we reach parity. And now, because of COVID, it looks like the curve will actually change for the worse.

Maybe that fact will be so worrisome that people will unite to push the curve toward equity more quickly, Jagsi says. Thats my hope.

See the original post here:
How COVID-19 threatens the careers of women in medicine - AAMC